Next Article in Journal
Multi-Targeted Molecular Docking, Pharmacokinetics, and Drug-Likeness Evaluation of Okra-Derived Ligand Abscisic Acid Targeting Signaling Proteins Involved in the Development of Diabetes
Next Article in Special Issue
Preparation of Hop Estrogen-Active Material for Production of Food Supplements
Previous Article in Journal
Synthesis and Characterization of Manganese Dithiocarbamate Complexes: New Evidence of Dioxygen Activation
Previous Article in Special Issue
Isolation, Characterization, Complete Structural Assignment, and Anticancer Activities of the Methoxylated Flavonoids from Rhamnus disperma Roots
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 26
Issue 19
10.3390/molecules26195956
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

An Update on Phytochemicals and Pharmacological Activities of the Genus Persicaria and Polygonum

by
Gisela Seimandi
1,†,
Norma Álvarez
1,†,
María Inés Stegmayer
1,
Laura Fernández
1,
Verónica Ruiz
1,*,
María Alejandra Favaro
1 and
Marcos Derita
1,2,*
1
ICiAgro Litoral, CONICET, Facultad de Ciencias Agrarias, Universidad Nacional del Litoral, Kreder 2805, Esperanza 3080HOF, Argentina
2
Farmacognosia, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, Rosario S2002LRK, Argentina
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Molecules 2021, 26(19), 5956; https://doi.org/10.3390/molecules26195956
Submission received: 1 September 2021 / Revised: 22 September 2021 / Accepted: 25 September 2021 / Published: 1 October 2021
(This article belongs to the Special Issue Natural Product-Inspired Molecules: From Weed to Remedy)
Review Reports Versions Notes

Abstract

:
The discovery of new pharmaceutical identities, particularly anti-infective agents, represents an urgent need due to the increase in immunocompromised patients and the ineffectiveness/toxicity of the drugs currently used. The scientific community has recognized in the last decades the importance of the plant kingdom as a huge source of novel molecules which could act against different type of infections or illness. However, the great diversity of plant species makes it difficult to select them with probabilities of success, adding to the fact that existing information is difficult to find, it is atomized or disordered. Persicaria and Polygonum constitute two of the main representatives of the Polygonaceae family, which have been extensively used in traditional medicine worldwide. Important and structurally diverse bioactive compounds have been isolated from these genera of wild plants; among them, sesquiterpenes and flavonoids should be remarked. In this article, we firstly mention all the species reported with pharmacological use and their geographical distribution. Moreover, a number of tables which summarize an update detailing the type of natural product (extract or isolated compound), applied doses, displayed bioassays and the results obtained for the main bioactivities of these genera cited in the literature during the past 40 years. Antimicrobial, antioxidant, analgesic and anti-inflammatory, antinociceptive, anticancer, antiviral, antiparasitic, anti-diabetic, antipyretic, hepatoprotective, diuretic, gastroprotective and neuropharmacological activities were explored and reviewed in this work, concluding that both genera could be the source for upcoming molecules to treat different human diseases.

1. Introduction

Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, parasites or fungi and can be transmitted, directly or indirectly, from one person to another. In the last decades, the rapid population growth, poverty, urban migration, international travels and environment changes have increased the exposure to several infectious agents [1]. According to the World Health Organization’s estimations, infectious diseases constitute one-third of all deaths in the world. Despite the pharmaceutical efforts to design new antibiotics for the treatment of these diseases, the acquisition of microorganisms’ resistance represents a worldwide concern, and this is attributed to the indiscriminate and improper use of current antimicrobial drugs [2]. For this reason, there is a need to search for alternative anti-infective substances, for example, antimicrobials of plant origin.
Plants have developed different active principles for defense towards the pathogens’ attacks, called secondary metabolites. Phenolic compounds (e.g., coumarines and phytoalexins), terpenoids (e.g., monoterpenes, saponins, steroids) and nitrogen compounds (e.g., alkaloids and lectins) are some secondary metabolites with biocidal capacity against human pathogens [3,4]. It has been estimated that 14–28% of higher plant species are used medicinally [5]. The use of antimicrobials of plant origin has many advantages [6]: they have no secondary effects, better patient tolerance, are less expensive, increase the bioavailability of free agents and demonstrate adequate therapeutic effect with relatively small doses.
The genus Polygonum comprises 250 species (20 represented in Argentina) of annual and perennial herbs distributed from the northern temperate to tropical and subtropical regions, preferably in low and humid areas, on the banks of streams and rivers. Nowadays, these species are classified into the Persicaria and Polygonum genera, according to botanical and phytochemical characteristics. Particularly, flavonoids and sesquiterpenes have played an important role in the systematics of Polygonum species as a chemotaxonomic marker and contributed to the regrouping of these species into Persicaria and Polygonum genera [7]. Species of Persicaria and Polygonum show different biological properties for, e.g., antiseptic, antibiotic [8], antinociceptive [9], antifungal [8,10,11], diuretic, antirheumatic, astringent [12,13] uses, and for the treatment of external infections such dermatoses, ulcers and sores [13,14].
The selection of the manuscripts for this review was based on the following inclusion criteria: articles published in English in the last three decades, with the keywords Persicaria, Polygonum and anti-infective in the title, abstract or full text. The authors firstly selected articles according to the title, then to the abstract and then through an analysis of the publication full text. The resulting articles were manually reviewed with the goal of identifying and excluding the works that did not fit the criteria described above. For scientific names of species, The Plant List updated database nomenclature was followed (www.theplantlist.org (accessed on 1 October 2021)).

2. Pharmacological Uses and Phytochemical Composition of Persicaria and Polygonum Species

The Persicaria and Polygonum genera are known for their wide spectra of properties to treat different diseases (Table 1). This is possible due to the capacity to produce a great variety of secondary metabolites such sesquiterpenes containing dialdehydes as functional groups [15]; flavonoids [7,16]; neoflavonoids [17]; triterpenes [18,19]; lignans [20]; other types of phenolic compounds not included among flavonoids subclass [21]; phenylpropanoids [22,23]; phenolic compounds belonging to the tannins type [24]; coumarins [17,18]; and anthraquinones [23].

3. Pharmacological Activities of Persicaria and Polygonum Products: Different Type of Extracts and Compounds Responsible for the Bioactivities

The following paragraphs will summarize, mainly in table format, the major biological activities depicted in the literature for these plant genera, not only for the different type of extracts generated from them but also for the pure compounds isolated. The parts of each species used to obtain the bioactive phytochemicals and a summary of the results, thrown by the displayed bioassays, will be also comment.

3.1. Antimicrobial Activity

Many authors all over the world have investigated the ability of Persicaria and Polygonum species to treat human fungal and bacterial pathogens. Table 2 summarizes the plants which show antimicrobial capacities against different fungal and bacterial strains.
From the analysis of Table 1, it could be stated that the three main bioassays displayed for detecting antimicrobial activities of different type of extracts of Polygonum or Persicaria species, as well as their bioactive compounds, include the percentage of microorganism growth inhibition, the determination of IC50 or the Minimum Inhibitory Concentration of each tested sample (extract or isolated compound). The last one constitutes a standard method for detecting antimicrobial susceptibility, so that the results obtained from carrying out these bioassays should be more convincing. In this sense, P. acuminata, P. ferruginea, P. hydropiperoides, P. lapathifolia and P. arenastrum were tested only as antifungals against yeasts or filamentous fungi, resulting in P. acuminata and P. ferruginea being the most active ones (MICs between 3.9 and 125 µg/mL). Authors correlated these promising activities with the presence of the sesquiterpene polygodial in P. acuminata extracts [25] and the chalcones cardamonin and pashanone present in P. ferruginea extracts [8]. Moreover, P. chinensis, P. hydropiper, P. maculosa, P. punctata, P. senegalensis, P. aviculare and P. cognatum resulted in both antifungals and antibacterials, highlighting the MICs values obtained for isolated compounds confertifolin and drimenol from P. hydropiper essential oil and polygodial from its chloroformic extract (MICs between 0.39 and 125 µg/mL comparable with standard drugs) [71,72,73,74,75]. Finally, P. capitata, P. glabra, P. minor, P. tinctoria and P. perfoliatum were reported in the literature only as antibacterials, remarking the high activity against S. aureus, E. coli, K. pneumoniae and N. gonorrhoeae of flavonoid-enriched fractions of aqueous extracts of P. capitata (MICs comparables to ciprofloxacin) [48]. These results are promising but limited to the in vitro evaluation, and thus, more studies regarding solubilities, absorption, blood distribution, pharmacodynamics, pharmacokinetics and tissue toxicity should be performed before these extracts or compounds could become remedies.

3.2. Antioxidant Activity

Species of the Persicaria and Polygonum genera have a remarkable antioxidant activity, as some compounds can remove the excess of free radicals in bodies to maintain normal metabolisms. Table 3 summarizes the most interesting results found in the literature for the following antioxidant bioassays performed: DPPH (2,2-diphenyl-2-picryl hydroxyl); TEAC (Trolox Equivalent Antioxidant Capacity); CUPRAC (Cupric Reducing Antioxidant Capacity); ABTS ((2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)); NBT (Nitroblue tetrazolium); FRAP (Ferric Reducing Antioxidant Power); ORAC (Oxygen Radical Absorbance Capacity assay); and CCA (Copper Chelating Activity).
From the analysis of this table, it could be remarked that gallic, chlorogenic and ellagic acids may be the responsible for the strong antioxidant activities showed by P. equisetiforme, P. lapathifolia, P. amplexicaulis, P. chinense var. chinense, P. chinense var. hispidum, P. bellardii, P. paleaceum and P. sagittata, which in many experiments resulted to be even more potent than the standard drugs. On the other hand, some specific compounds such as persilben, amplexicine, quercitrin and brevifolin carboxylic acids, vanicoside A and B and taxifolin, were associated to the antioxidant response during the different bioassays carried out with P. maculosa, P. amplexicaulis, P. chinense var. chinense, P. chinense var. hispidum, P. sagittata and P. orientalis, respectively. Conspicuously, a study performed with MeOH extract and zinc oxide nanoparticles (ZnO-NPs) of P. bistorta inhibited the ABTS radicals with an IC50 value of 40 µg/mL, and it was observed that the activity was dose-dependent. Moreover, it is well known that phenolic compounds are widespread in the plant kingdom, acting as antioxidants offering plant protections, so the Persicaria and Polygonum genera are not exceptional.

3.3. Analgesic and Anti-Inflammatory Activity

Many species of the Persicaria and Polygonum genera present anti-inflammatory properties, which are described in Table 4.
From the analyses in Table 4, it could be observed that unlike the bioactivities described in the previous tables, for the evaluation of analgesic and anti-inflammatory effects, the whole extract of each species was evaluated more than the isolated compounds. Oppositely, more in vivo studies were informed for these bioactivities. The MeOH extract of P. chinensis exhibited anti-gastric activity compared with the standard ranitidine, but this effect was not correlated with the presence of any compound. The same fact occurred with the MeOH extract of P. alpina, which showed anti-inflammatory abilities compared to the standard Indomethacin, and with the MeOH extract of P. lapathifolium var. lanatum, which offered analgesic activity at the same level of the standard aminopyrine. These results could be explained by the synergistic effects of the compounds present in the MeOH extracts instead of the specific action of any compound present in them. On the other hand, α-Santalone (isolated from the MeOH extract of P. pubescens) demonstrated to be the responsible for the potent analgesic activity of the extract, while flavonoids and sesquiterpene lactones may be responsible for the anti-inflammatory effect of P. jucundum. Finally, quercetin-3-O-β-d-glucuronide isolated from P. perfoliatum suppressed ear edema and peritoneal permeability in mice showing higher inhibition percentage respect to aspirin.

3.4. Antinociceptive Activity

Antinociceptive activities of the n-Hex, EtOAc and MeOH extracts from P. hydropiper were tested by acetic-acid-induced writhing method in Swiss albino mice of either sex [81]. Ethyl acetate extract showed a moderate dose-dependent effect, with writhing inhibition of 54.95% at a dose of 500 mg/kg compared with the standard aminopyrine (inhibition of 73.62% at dose of 50 mg/kg). Additionally, Oany et al. [82] reported that crude EtOH extract of P. hydropiper leaves exhibited a good antinociceptive activity compared to the standard drug aspirin, displaying a reduction in the abdominal writhing’s number of 41.02% and 69.23%, respectively, at a dose of 400 mg/kg b.w. Petroleum ether and chloroform (Chl) extracts of P. barbata showed antinociceptive properties, with an inhibition of writhing response of 46.8% and 44.8%, respectively (at a dose of 400 mg/kg b.w.), compared to 62.2% for the positive control aminopyrine [35]. The authors concluded that the compounds responsible for this activity were of apolar nature, possibly sterols or terpenoids. With respect to P. acuminata, the EtOH extracts of the leaves and stems exhibited antinociceptive activities with a percentage of writhing inhibition of 53.57% and 50%, respectively, at a dose of 500 mg/kg, similar values compared to the standard diclofenac (57.7% at a dose of 25 mg/kg) [9]. The antinociceptive activity of the crude MeOH extract of P. verticillatum rhizomes was tested by Khan et al. [193]. They found that at dose-dependency and through an opioid system, the extract could significantly reduce (72%) the number of writhes induced by acetic acid. The extract contained a high content of saponins and alkaloids.

3.5. Anticancer, Antitumoral and Cytotoxic Activity

Anticancer and antitumoral activities displayed by Persicaria and Polygonum species were studied in over the world. Many of these species have inhibitory abilities against different cancerogenic cell lines (Table 5): Jurkat, HL60, THP-1, CCRF-CEM, K562, U-937, K562 and P338 (human leukaemia); HepG2, Huh-7, SMMC-7721, HCCLM3, Hep3B (hepatocellular carcinoma); CaCo-2, HCT116, HT-29, CT-26, RKO, Colo320 and SW620 (colon cancer); MCF-7, HTB-26, MDA-MB-231-pcDNA3, MDA-MB-435 and Bcap-37 (breast cancer); SiHa, HeLa and PC-3 (cervical carcinoma); PC3 and PC3 (prostate carcinoma); LL2, A549, 95D and NCI H460 (lung carcinoma); SNU-601 and SGC-7901 (gastric cancer); PANC-1 (pancreatic adenocarcinoma); H22 (murine H22 ascitic hepatoma); EAC (Ehrlich ascites carcinoma); EBV-EA (Epstein-Barr virus early antigen); J82 (bladder transitional carcinoma); HEK 293 (renal cancer); NU-1066 (laryngeal cancer); OVCAR-3 (ovarian cancer); U87MG and BT-325 (glioblastoma); CAL 27 (oral adenosquamous carcinoma); Smur180 (sarcoma); and NIH3T3 (fibroblast).
According to this information, flavonoids glucosides provide the antitumoral activities to P. amphibia, P. aplexicaulis, P. decipiens, P. glabra, P. limbate and P. senegalensis with IC50 values varying from 0.01 to 100 µM depending on the cellular type under study. Other compounds such as gallic acid, ellagic acid and steroids seem to be responsible for the antitumoral activities of P. bistorta, P. chinensis, P. hydropiper and P. bellardii but show lower IC50 than flavonoids. Some specific compounds such as amplexicaule A, vanicoside B, lapathoside A and polygonumin A isolated from P. amplexicaulis, P. lapathifolia and P. minor, respectively, showed promising anticancer activities with IC50 values comparable to standard drugs.

3.6. Antiviral Activity

Some Persicaria and Polygonum species have shown antiviral abilities against different types of viruses (Table 6): HHV-1 and HSV-1 (human herpes virus 1); EBV-EA (Epstein-Barr virus); H1N1 A/PR/8/34, H1N2 A/HK/8/68 and B/Lee/40 (influenza A y B); HIV-1VB59 and HIV-1UG070 (immunodeficiency human virus); VACV-WR (vaccinia virus strain Western Reserve); VV (vaccinia virus); DEN-2 (dengue virus 2); VSV (vesicular stomatitis virus); RSV (respiratory syncytial virus); MCMV (cytomegaly virus); and HBV (hepatitis B virus). It could be highlighting the inhibition of HIV-1 protease (56%) of polygonumins A isolated from P. minor and the HIV-1 reverse transcriptase inhibitory activity of viscoazulone isolated from P. viscosum.

3.7. Antiparasitic Activity

Extracts and isolated compounds from Persicaria and Polygonum species were tested against different parasites that cause human diseases such as Plasmodium falciparum (causal agent of malaria disease); Trypanosoma cruzi and T. brucei (causal agents of Chagas disease); Leishmania amazonensis and L. tropica (causal agents of leishmaniasis disease); and Pheretima posthuma and other parasitic earthworms (which cause helminth infections). Results of these investigations are show in Table 7.
Few antiparasitic studies have been conducted using these two plant genera, and most of them were carried out with extracts. It could be remarked the anti-trypanocide activities of two chalcones obtained from P. decipiens, which showed IC50 values compared to the standard drugs diminazene and pentamidine against T. brucei and T. congolense. In addition, saponins from the butanolic extract of P. hydropiper displayed anti-leishmanial actions similar to the standard drug piperazine citrate.

3.8. Anti-Diabetic Activity

The anti-diabetic ability of EtOH extract from P. aviculare leaves was tested by Cai et al. [163]. The results showed that the extract is a potent inhibitor of α-glucosidase levels, higher than the standard drug acarbose, with IC50 values of 21.42 and 176.79 μg/mL, respectively. Additionally, the compounds myricitrin, quercetin, polydatin and isoquercitrin (present in the phenolic portion of P. aviculare extracts) were primarily responsible for this activity, with IC50 values of 8.65, 15.17, 35.15 and 148 μg/mL, respectively [163]. Ethanol extract of P. pulchra leaves showed a good α-glucosidase (involved in Type 2 diabetes mellitus) inhibition with IC50 value of 22.67 mg/mL, respect to the positive control acarbose (7.77 g/mL) [134]. In addition, Oany et al. [82] tested antihyperglycemic activity of crude EtOH extracts from leaves and stems of P. hydropiper and found that for all the doses tested (50, 100, 200 and 400 mg/kg b.w.), leaves’s extract showed higher effectiveness than standard glibenclamide, diminishing blood glucose levels between 48.8 and 58.2% for the extract and 42.1% for glibenclamide (at dose 10 mg/kg b.w.). Furthermore, the extracts of the leaves and stems (principally n-Hex, Chl and MeOH extracts) displayed α-amylase inhibitory activities, with IC50 values between 1.03 and 3.517 mg/mL [75]. This enzyme can increase the blood sugar level, as hydrolyses (1,4)-α-d-glycosidic linkages in polysaccharides contain three or more (1,4)-α-linked D-glucose units. Another study demonstrated that the EtOH extract of P. cognatum strongly inhibited α-amylase activity (86.6%) and moderately inhibited α-glucosidase activity (41.05%) with respect to the standard acarbose (58.4% and 57.56%, respectively) [169].
Kubinova et al. [97] tested the anti-diabetic activity of isolated compounds from the MeOH extract of P. lapathifolia aerial parts by the inhibition of AChE, BuChE and α/β-glucosidase. At a dose of 100 μM, kaempferol showed the highest inhibition of AChE (60.4%) and BuChE (74.5%), compared to the standard galantamine (95.7 and 47.9%, respectively), while gallic acid was only effective on AChE (inhibition of 51.2%). With respect to the α-glucosidase inhibitory assay, all isolated flavonoids showed potent enzyme inhibitory activity (72.6–97.2%) and eightfold higher activity than standard acarbose (11.4%), while for the β-glucosidase inhibitory assay, only quercitrin and isoquercitrin inhibited the enzyme with higher efficacy than the standard quercetin (23.6, 23.4 and 16.7%, respectively). Rodrigues et al. [177] tested the anti-diabetic ability of the leaf and root extracts of P. maritimun on α-amylase, baker’s yeast (α-glucosidase) and rat’s α-glucosidases. Both the MeOH and DCM extracts showed IC50 values lower than the positive control (acarbose) on α-glucosidase, but the MeOH extract had the highest capacity to inhibit the baker’s yeast α-glucosidase, with an IC50 value significantly lower than that of acarbose (IC50 value of 19 and 29 µg/mL for roots and leaves; 3144 µg/mL for acarbose).
The anti-hyperglycaemic effect of aqueous extract of P. orientalis flowers was tested on streptozotocin (STZ)-induced diabetic mice [130]. At a dose of 200 mg/kg, it was observed the most potent results: the extract significantly decreased blood glucose levels (144 mg/mL, 21 days) and serum cholesterol (53.2 mg/dL) compared to the control (210.06 and 82.4 mg/dL, respectively) and increased glycogen content in liver (30.7 mg/g for treatment and 11.86 mg/g for diabetic control). The hydroalcoholic (50%) extract of P. senegalensis leaves exhibited a potent anti-diabetic activity, inhibiting 100% of the α-glucosidase activity at a concentration of 10 ug/mL [144].

3.9. Antipyretic Activity

The antipyretic activity of the aqueous root extract of P. bistorta was studied in albino rats with Brewer’s-yeast-induced fever [45]. At a concentration of 100 mg/kg and after 4 h of treatment, the extract exhibited similar pyrexia activities to that of the standard drug acetaminophen, with a decrease in the rectal temperature of 0.8 °C. Another study revealed that the MeOH root extract of P. glabra exhibited a significant dose-dependent antipyretic activity on albino rats submitted to the Brewer’s-yeast-induced hyperpyrexia method [68]. Alkaloids, flavonoids and phenolic compounds could be responsible for this activity. Finally, Akhter et al. [89] tested the antipyretic activity of MeOH, EtOH, Chl, petroleum ether and n-Hex extracts of P. hydropiper leaves on Albino Swiss mice of both sexes. At doses of 200 and 400 mg/kg b.w., the MeOH, EtOH and Chl extracts showed a good activity compared to the standard drug paracetamol (50 mg/kg b.w.) by reducing temperature up to 4–7%, approximately.

3.10. Hepatoprotective Activity

El-Toumy et al. [172] tested the hepatoprotective activity of the MeOH extract of P. equisetiforme’s aerial parts on CCl4-induced hepatic illness in Sprague-Dawley rats by measuring the levels of serum marker enzyme activities (alanine amino transferase-ALT and aspartate amino transferase-AST) and the oxidative stress mediator levels (NO, malondialdehyde-MDA, glutathione-GSH, glutathione peroxidase-GPx and superoxide dismutase-SOD). The results showed that when the rats were pre-treated with the extract, they exhibited normal levels of ALT and AST (64.86 and 45.16 IU/mL, respectively, at an extract dose of 200 mg/kg) compared to the control (64.86 and 44.22 IU/mL). The GSH, GPx and SOD levels decreased, while the NO and MDA levels increased in comparison to the control. On the other hand, Christapher et al. [119] assessed the hepatotoxicity ability of the MeOH extract obtained from the leaves of P. minor on CCl4 and paracetamol-induced hepatotoxicity in Sprague-Dawley rats. They found that this extract significantly decreased the levels of AST, ALT, ALP and TB in both models compared to the CCl4 and paracetamol controls. At dose-dependency, the MeOH extract of P. glabra roots reduced the marker levels of hepatic injury such as serum glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), alkaline phosphatase (ALKP) and total bilirubin in CCl4 and paracetamol-induced rats [120].
The anti-fibrotic effects of the aqueous and organic extracts of P. plebeium (whole plant) on inflammatory liver disease in CCl4-induced rats were tested, and the authors found that the extracts reduced the ALT, AST and gamma-glutamyl transpeptidase (γGT) levels in CCl4-induced rats and restored the CCl4-induced tissue fibrosis [190]. In addition, the aqueous extract from the roots of P. bistorta exhibited significant hepatoprotective effect in rats with CCl4-induced liver damage: the CCl4 administration on hepatic cells showed hydronic degeneration, swelling, congestion in portal vessels and sinusoids and optically empty cytoplasmic areas and increased the AST, ALT and total bilirubin levels in rats (173 and 223 IU/L and 1.15 mg/dL, repsectively) compared to the control (67.7 and 48.2 IU/L and 0.53 mg/dL, respectively). However, the cells recoupment when they were treated with aqueous roots extract of P. bistorta at a concentration of 100 mg/kg (levels of AST, ALT and total bilirubin decreased at 88.5 and 98.3 IU/L and 0.75 mg/dL, respectively) [46].
The hepatoprotective effects of the MeOH, EtOH and aqueous extracts of P. amplexicaulis rhizomes on albino mice were tested [34]. After the administration of CCl4 to the mice’s, ALT, AST, ALP and plasma bilirubin levels increased, and body weight decreased compared to the control; these levels were recouped when administrated aqueous, MeOH and EtOH extracts at a dose of 200 mg/kg. ALT, AST, ALP and plasma bilirubin decreased and body weight increased by 16.3, 12.96 and 8.08%, respectively, compared to the control silymarin (10.88% at a dose of 100 mg/kg). Furthermore, the EtOH fruit extract of P. orientalis exhibited significant hepatoprotective effects against CCl4-induced acute liver injury (ALI) in rats [131]. At doses of 0.5 and 1 g/kg of extract, the levels of AST, ALT, ALP, NO, tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6) decreased, while the levels of SOD, GPx and GRd increased. Protocatechuic acid, taxifolin, and quercetin identified by HPLC in the extracts, might be mainly responsible for these effects. In addition, Fan et al. [132] tested the potential inhibitory ability of OATP1B1 (anion transporting polypeptide 1B1, associated with drug-induced liver injury) of flavonoids isolated from P. orientalis. The results demonstrated that the compounds isoorientin and orientin showed weak inhibitory effects on OATP1B1-mediated fluvastatin consumption in OATP1B1-HEK293 cells (27.72 and 23.3%, respectively). Nguyen et al. [135] reported that the EtOAc extract from the aerial parts of P. pulchra and its subfractions exhibited a potent hepatoprotective activity in CCl4-induced rats since it reduced ALT activity between 50 and 68%. Finally, Xu et al. [189] reported that the total flavonoids isolated from P. perfoliatum exhibited potential hepatoprotective effect in CCl4-exposed mice, decreasing liver functional enzymes (ALT and AST), TNF-α, interleukin 6 and heat shock protein 90 (Hsp90) and increasing intrasplenic integrin β1, 5′-nucleotidase and antigen KI-67 cells at doses of 60 and 120 mg/kg/day.

3.11. Neuropharmacological Activity

3.11.1. Anti-Alzheimer’s

The potential of β-sitosterol isolated from P. hydropiper for the management of Alzheimer’s disease was tested [90]. Authors observed a significant decline in free radical’s load in the brain tissues of the β-sitosterol-treated animals, with IC50 values of 140, 120, and 280 μg/mL from DPPH, ABTS and H2O2 assays, respectively. In addition, they performed memory assessment and coordination tasks (SWM, Y-maze and balance beam tests) and found that β-sitosterol-treated animals had gradual improvement in working memory and in motor coordination [90]. Previously, Ayaz et al. [78] reported that essential oil from the leaves and flowers of this plant demonstrated a significantly acetylcholinesterase (AChE) inhibitory ability (inhibition of 87 and 79.66%; IC50 = 120 and 220 μg/mL, respectively) and a butyrylcholinesterase (BChE) inhibition of 82.66 and 77.5%; IC50 of 225 μg/mL, respectively. Caryophyllene oxide and decahydronaphthalene were identified as the major components of the leaves’ and flower’s essential oils, respectively. Ahmad et al. [113] tested the AChE inhibition ability of different extracts (MeOH, EtOH, aqueous, DCM and n-Hex) and the essential oil of the leaves, stem and root of P. minor. Aqueous and MeOH leaf extracts showed the higher AChE inhibitory activity, with IC50 values of 234 and 342.77 µg/mL, respectively; root extracts had the lowest AChE inhibitory activity (IC50 > 1000 µg/mL). The presence of terpenoids could explain AChE activity of MeOH and aqueous extracts, as it can readily cross the blood–brain barrier by its small size and lipophilicity [113]. In addition, a study revealed that the aqueous extract of this plant could reverse scopolamine-induced memory deficits in a Barnes maze model (at a dose of 100 mg/kg) and could inhibit AChE activity by 68% with an IC50 of 0.04 mg/mL [121]. Regarding P. glabra, the MeOH and EtOH extracts of its aerial parts exhibited neuroprotective activity against AlCl3-induced (aluminium chloride) toxicity in rats, improving learning and memory and decreasing AChE levels at similar values of the standard rivastigmine at a concentration of 400 mg/kg [69]. Another study stated that the MeOH extracts from roots and aerial parts of P. maritimum could be a good alternative for the treatment of neurodegenerative disorders such as Alzheimer’s disease due to the ability for the inhibition of AChE and tyrosinase (TYRO), with IC50 values of 0.17 and 0.27 mg/mL for AChE and 0.59 and 0.6 mg/mL for TYRO [178].

3.11.2. Anti-Depressant and Sedative

The anti-depressant activity of the aqueous extract of P. glabra was tested by Nizar et al. [70]. The results showed that the extract, in a dose-dependent manner (50, 100 and 200 mg/kg), induced a significant decrease in the immobility time of mice during behavioural despair test (BDT) and tail suspension test (TST) and increased the hyperactivity scores in an L-dopa-induced hyperactivity test, with similar values to the reference Imipramine (15 mg/kg). The depressant activity of four sesquiterpenes (viscosumic acid, viscozulenic acid, viscoazucine and viscoazulone) and the flavonoid glycoside quercetin-3-O-(6-feruloyl)-β-d-galactopyranoside isolated from the aerial parts of P. viscosum was tested by open-field test [196]. Viscoazucine and viscoazulone were the most potent depressants, showing gradual decreases in the movement of mice (No. of movements at 0 min = 143.97 and 137.95 and at 240 min = 23.92 and 27.93, respectively), while the other compounds showed a moderate depressant activity.
P. hydropiper showed anti-depressant and sedative activity: Sharif et al. [91] tested the antidepressant activity of the MeOH, EtOH and Chl leaf extracts by open field test and swimming test (mice were forced to swim and scored immobility). At a dose of 150 mg/kg, the Chl and EtOH extracts significantly decreased movements and exerted immobile phase in mice similar to the standard Imipramine (10 mg/kg). Devarajan et al. [92] examined the depressor effect of extracts of P. hydropiper leaves in salt-induced hypertension in mice and found that both could reduce blood pressure and heart rate in a dose-dependent manner. Shahed-Al-Mahmud and Lima [93] revealed that the MeOH leaf extract presented a good sedative and anxiolytic activity (at a concentration between 50 and 500 mg/kg) compared to a positive control of diazepam (1 mg/kg) using different test types such as open field test and thiopental sodium-induced sleeping time test in mice (for sedative activity) and elevated-plus maze and light-dark box (for anxiolytic activity). Finally, the ion channel-blocking activity K + of G protein-activated inwardly (responsible for maintaining the resting membrane potential and cell excitability) of different extracts of P. maculosa were tested through the automated patch-clamp method [109]. They found that Chl extract and its HPLC eluate fractions, at a concentration of 0.1 mg/mL, showed a potent K + channel-inhibitory activity compared to the reference compound Propafenone (between 62 and 76% and 71 and 81%, respectively).

3.11.3. Neuroprotective Activity

Won and Ma [164] tested the neuroprotective activity of the aqueous-MeOH extract of P. aviculare by glutamate-induced neurotoxicity assay in primary cultures of rat cortical cells assay. The results showed that at a concentration of 100 µg/mL, a good neuroprotective potency of 50.1% compared to the standards CNQX (59.2%) and MK-801 (70.8%) was observed. Additionally, the juglandin extracted from crude P. aviculare exhibited a good neuroprotective activity in mice with LPS-induced Parkinson’s disease, attenuating memory impairments, promoting the expression of synaptic markers (SYP, PSD-95 and SNAP-25), decreasing production of pro-inflammatory cytokines (IL-1β, TNF-α, IL-18 and COX-2) and blocking TLR4/NF-κB pathway [165]. In addition, the extract of P. aviculare was tested for its neuro-inflammatory properties, and it was found that the extract could decrease lethargy-like behaviour and the compounds corticosterone, serotonin, and catecholamines (fatigue-related) in the brain and inhibited the production protein TNF-α (tumour necrosis factor) [166]. Finally, the neuroprotector effect of orientin (pyrone glucoside extracted from P. orientalis) was tested in pheochromocytoma cell line (PC12) stimulated by H2O2 in mice [133]. The results demonstrated that orientin was not toxic for PC12 cells and could reduce the H2O2-induced viability of PC12 cells at higher concentrations than 40 µg/mL. Moreover, orientin decreased H2O2-induced phosphorylation of signaling proteins (MAPKs, AKT and Src) and inhibited ROS (causing neurodegenerative diseases) accumulation in cells [133].

3.12. Diuretic Activity

In a Lipschitz test, the petroleum ether, Chl and EtOAc extracts of P. barbata’s aerial parts exhibited dose-dependent diuretic activity, but EtOAc extract (at a dose of 400 mg/kg) showed the most significant effect after 2 h of administration (diuretic activity = 1.77) compared to the standard Furosemide (diuretic activity = 1.72) [35]. In addition, the EtOAc extract of P. lapathifolium var. lanatum demonstrated a moderate to good diuretic activity, with values of 1.422 and 1.87 at doses of 150 mg/kg and 300 mg/kg b.w., respectively [98]. Finally, the diuretic activity of α-Santhalone isolated from P. pubescens aerial parts was tested by the Lipschitz methods, and it was found that at a concentration of 40 mg/kg, this compound presented a good activity after the first hour of administration (diuretic activity = 1.24) compared to the standard Furosemide 3 mg/kg (diuretic activity = 1.81) [191].

3.13. Gastroprotective Activity

The anti-ulcer activity of the alcoholic and aqueous extracts of P. barbata were tested by Pylorus ligation models and ethanol-induced gastric mucosal injury in rats [38]. They found that both extracts, in a dose-dependent manner, could significantly reduce the number and index of ulcers and total acidity, as well as increasing the pH index. The compounds present in both extracts such as saponins, sterols, glycosides and alkaloids could explain this activity [38]. In addition, the aqueous extract from the leaves of P. chinensis showed a gastroprotective effect against ethanol-induced gastric mucosal injuries in Sprague-Dawley rats, as it reduced gastric lesions and malondialdehyde levels (MDA) and increased superoxide dismutase level (SOD) [57]. The anti-ulcer activity of the aqueous extract from the leaves of P. minor against ethanol-induced gastric ulcers in rats was tested [122]. The extract showed a significant anti-ulcer activity compared to the standard omeprazole (20 mL/kg): at dose-dependentcy (250 and 500 mL/kg), the extract increased pH and gastric mucous, suppressed areas of gastric ulcer formation (35.33–188.17 mm) and inhibited 78.25–95.92% of the gastric ulcer. In addition, Qader et al. [123] obtained five fractions (hexane:ethyl acetate 1:1 v/v (F1), ethyl acetate:methanol 1:1 v/v (F2), methanol:acetonitrile 1:1 v/v (F3), acetonitrile:distilled water 1:1 v/v (F4) and distilled water 1:1 v/v (F5)) from the EtOH extract of the leaves of P. minor and tested its gastroprotective activity using the ethanol induction method in rats. All the fractions exhibited gastroprotective activity, but F2 showed the best result at a dose-dependency (very similar to Omeprazole values), inhibiting 90% of ulcer lesions and increasing mucus content (120 mg/g), SOD, hexosamine and PGE2 synthesis levels in the stomach wall mucosa.
The gastroprotective effect of the hydro-alcoholic root extract of P. bistorta was tested by indomethacin-induced gastric ulcer in rats [47]. At a dose-dependency (500 and 1000 mg/kg), this extract significantly increased mucus, SOD and catalase levels and decreased the ulcer index and thiobarbituric acid (TBARS), with similar values shown by the standard drug ranitidine (20 mg/kg), compared to the ulcer control group. Ayaz et al. [74] tested the gastroprotective ability of the crude MeOH extract from P. hydropiper and its fractions by aspirin-induced ulcerogenesis in rats. At a dose dependency (100, 200 and 400 mg/kg), the extract exhibited a good gastroprotective activity compared to the standard ranitidine (50 mg/kg), as it could decrease gastric juice volume, free acidity, total acidity and pepsin levels, as well as increased gastric juice pH levels. Additionally, the essential oil obtained from the leaves and saponins (fractions) showed the highest urease inhibition (> 70%, IC50 = 90 and 98 µg/mL, respectively) compared to the control drug thiourea (urease inhibition > 80% and IC50 = 80 µg/mL) [74].

3.14. Other Activities

The acetone extract from the aerial parts of P. maritimum is considered an interesting anti-melanogenic agent, as it was demonstrated to inhibit tyrosinase and melanin production in B16 4A5 melanoma cells, with IC50 values of 64.1 and 77.7 μg/mL, respectively [176]. Myricitrin, catechin and monogalloyl-hexose isolates could be responsible for this activity. Another study conducted by George et al. [124] explored the immunomodulatory properties of aqueous extract of P. minor, and they showed that this extract displayed significant phagocytic index (K) at doses of 200 and 400 mg/kg b.w. (K = 0.045 and 0.062, respectively) compared with the standard levamisole (K = 0.060). Finally, Kimura et al. [155] tested the inhibitory activity of flavonol O-glycosides isolated from 80% MeOH extracts of P. tinctorea leaves against HMG-CoA reductase. The fraction eluted with 100% MeOH showed the most potent inhibitory activity (56.7%), while five compounds isolated from this fraction were effective dose-dependently, inhibiting HMG-CoA reductase activity by 50 to 67.6%.

4. Conclusions

This Polygonum and Persicaria genera revision revealed the great variety of chemical constituents present in these plants, highlighting the bioactive groups of sesquiterpenes, flavonoids and phenolic acids. Methanolic, ethanolic, hexanic, ethyl acetate and water extracts and their fractions and chemical phytoconstituents have demonstrated different pharmacological activities such as antifungal, antibacterial, antioxidant, anti-inflammatory, anticancer and neuropharmacological activities in many publications, which were updated and revised here. These findings revealed that the species of the Persicaria and Polygonum genera could be property developed as good candidates for clinical assays in the future, allowing for the expansion of knowledge for the treatment of new diseases. P. glabra, P. hydropiper, P. minor, P. lapathifolia and P. chinensis were the species that showed the highest number of medicinal properties. Native species of Asia and Europe are ones with the largest number of studies in the world, followed by African species. However, American species are poorly studied or do not present any study (e.g., P. ferruginea, P. hydropiperoides, P. punctata and P. paraguayense), which invites the investigation of these species in the future.
The wide range of pharmacological properties of Polygonum and Persicaria species may offer a new therapeutic promise to cure different diseases and health complications. So, an accelerated progress should be made through experimental research including robust clinical trials, in order to generate natural medicines that allow to counter the negative effects on human health.

Author Contributions

The individual contributions of each author are as follows: Conceptualization, G.S., N.Á. and M.D.; formal analysis, G.S., L.F., M.I.S. and M.D.; investigation, G.S., N.Á., L.F. and M.A.F.; resources, M.A.F., V.R. and M.D.; writing—original draft preparation, G.S. and N.Á.; writing—review and editing, V.R. and M.D.; supervision, M.A.F., V.R. and M.D.; project administration, M.A.F., V.R. and M.D.; funding acquisition, V.R. and M.D. All authors have read and agreed to the published version of the manuscript.

Funding

Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET, PIP N° 524), Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT, PICT 2015–2259) and ASaCTeI.

Acknowledgments

G.S., N.Á., M.I.S. and L.F. thank CONICET for their fellowships.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Centers for Disease Control and Prevention. Addressing Emerging Infectious Disease Threats: A Prevention Strategy for the United States (Executive Summary); GPO: Washington, DC, USA, 1994; Volume 43, pp. 1–18. [Google Scholar]
  2. Usha, P.T.A.; Jose, S.; Nisha, A.R. Antimicrobial Drug Resistance-A global concern. Vet. World. 2010, 3, 138–139. [Google Scholar]
  3. Lizcano González, M.C. Evaluación de la Actividad Antifúngica del Extracto de Tomillo (Thymus vulgaris) contra Botrys cinerea, Fusarium oxysporum y Sclerotinia sclerotiorum. Ph.D. Thesis, Pontificia Universidad Javeriana, Bogotá, Colombia, 2007. [Google Scholar]
  4. Freiesleben, S.; Jäger, A. Correlation between plant secondary metabolites and their antifungal mechanisms–A review. Med. Aromat. Plants 2014, 3, 1–6. [Google Scholar]
  5. Farnsworth, N.R.; Soejarto, D.D. Global importance of medicinal plants. In Conservation of Medicinal Plants; Akerele, O., Heywood, V., Synge, H., Eds.; Cambridge University Press: Cambridge, UK, 1991; Volume 1, pp. 25–51. [Google Scholar]
  6. Chanda, S.; Rakholiya, K. Combination therapy: Synergism between natural plant extracts and antibiotics against infectious diseases. In Science against Microbial Pathogens: Communicating Current Research and Technological Advances; Méndez-Vilas, A., Ed.; Formatex Research Center: Badajoz, Spain, 2011; Volume 1, pp. 520–529. [Google Scholar]
  7. Derita, M.; Zacchino, S. Chemotaxonomic importance of sesquiterpenes and flavonoids in Argentinian species of Polygonum genus. J. Essent. Oil Res. 2011, 23, 11–14. [Google Scholar] [CrossRef]
  8. López, S.N.; Furlan, R.L.E.; Zacchino, S.A. Detection of antifungal compounds in Polygonum ferrugineum Wedd. extracts by bioassay-guided fractionation. Some evidences of their mode of action. J. Ethnopharmacol. 2011, 138, 633–636. [Google Scholar] [CrossRef]
  9. Saifuzzaman, M.; Shamim, M.S.J.; Mahaldar, K.; Ali, E.S.; Islam, M.A. Antinociceptive activity of the ethanolic extract of Persicaria acuminata Sach. J. Pharm. Res. 2013, 6, 753–755. [Google Scholar] [CrossRef]
  10. Derita, M.; Leiva, M.; Zacchino, S. Influence of plant part, season of collection and content of the main active constituent, on the antifungal properties of Polygonum acuminatum Kunth. J. Ethnopharmacol. 2009, 124, 377–383. [Google Scholar] [CrossRef]
  11. Derita, M.; Zacchino, S. Validation of the ethnopharmacological use of Polygonum persicaria for its antifungal properties. Nat. Prod. Commun. 2011, 6, 931–933. [Google Scholar] [CrossRef] [Green Version]
  12. Agüero, E. Plantas Medicinales Silvestres del Centro de Argentina: Guía para su Reconocimiento y uso Terapéutico; Ecoval Ediciones: Córdoba, Argentina, 2017; p. 443. [Google Scholar]
  13. Lahitte, H.B.; Hurrell, J.A.; Belgrano, M.J.; Jankowski, L.S.; Haloua, M.P.; Mehltreter, K. Plantas Medicinales Rioplatenses: Plantas Nativas y Naturalizadas Utilizadas en Medicina Popular en la Región del Delta del Paraná, Isla Martín García y Ribera Platense; L.O.L.A: Buenos Aires, Argentina, 1998; p. 240. [Google Scholar]
  14. Gupta, P.M. 270 Plantas Medicinales Iberoamericanas, Programa Iberoamericano de Ciencia y Tecnología para el Desarrollo; Subprograma de Química Fina Farmacéutica: Bogotá, Colombia, 1994; p. 567. [Google Scholar]
  15. Baharum, S.N.; Bunawan, H.; Ghani, M.A.A.; Mustapha, W.A.W.; Noor, M.N. Analysis of the chemical composition of the essential oil of Polygonum minus Huds. using two-dimensional gas chromatography–time-of-flight mass spectrometry (GC–TOF MS). Molecules 2010, 15, 7006–7015. [Google Scholar] [CrossRef] [Green Version]
  16. Huda-Faujan, N.; Noriham, A.; Norrakiah, A.S.; Babji, A.S. Antioxidative activities of water extracts of some Malaysian herbs. ASEAN Food J. 2007, 14, 61–68. [Google Scholar]
  17. Sun, X.; Sneden, A.T. Neoflavonoids from Polygonum perfoliatum. Planta Med. 1999, 65, 671–673. [Google Scholar] [CrossRef]
  18. Sun, X.B.; Zhao, P.H.; Xu, Y.J.; Sun, L.M.; Cao, M.A.; Yuan, C.S. Chemical constituents from the roots of Polygonum bistorta. Chem. Nat. Compd. 2007, 43, 563–566. [Google Scholar] [CrossRef]
  19. Bouzada, M.L.; Fabri, R.L.; Nogueira, M.; Konno, T.U.; Duarte, G.G.; Scio, E. Antibacterial, cytotoxic and phytochemical screening of some traditional medicinal plants in Brazil. Pharm. Biol. 2009, 47, 44–52. [Google Scholar] [CrossRef]
  20. Wang, K.W.; Zhu, J.R.; Shen, L.Q. A new lignan with anti-tumour activity from Polygonum perfoliatum L. Nat. Prod. Res. 2013, 27, 568–573. [Google Scholar] [CrossRef] [PubMed]
  21. Maizura, M.; Aminah, A.; Wan Aida, W.M. Total phenolic content and antioxidant activity of kesum (Polygonum minus), ginger (Zingiber officinale) and turmeric (Curcuma longa) extract. Int. Food Res. J. 2011, 18, 526–531. [Google Scholar]
  22. Takasaki, M.; Kuroki, S.; Kozuka, M.; Konoshima, T. New phenylpropanoid esters of sucrose from Polygonum lapathifolium. J. Nat. Prod. 2001, 64, 1305–1308. [Google Scholar] [CrossRef]
  23. Zhang, X.; Liu, F.; Feng, Z.M.; Yang, Y.N.; Jiang, J.S.; Zhang, P.C. Bioactive phenylpropanoid esters of sucrose and anthraquinones from Polygonum cuspidatum. Fitoterapia 2020, 146, 104673. [Google Scholar] [CrossRef]
  24. Wang, K.J.; Zhang, Y.J.; Yang, C.R. Antioxidant phenolic compounds from rhizomes of Polygonum paleaceum. J. Ethnopharmacol. 2005, 96, 483–487. [Google Scholar] [CrossRef]
  25. Derita, M.; Montenegro, I.; Garibotto, F.; Enriz, R.; Fritis, M.C.; Zacchino, S. Structural requirements for the antifungal activities of natural drimane sesquiterpenes and analogues, supported by conformational and electronic studies. Molecules 2013, 18, 2029–2051. [Google Scholar] [CrossRef]
  26. Calderón, Á.I.; Romero, L.I.; Ortega-Barría, E.; Solís, P.N.; Zacchino, S.; Gimenez, A.; Pinzón, R.; Cáceres, A.; Tamayo, G.; Guerra, C.; et al. Screening of Latin American plants for antiparasitic activities against malaria, Chagas disease, and leishmaniasis. Pharm. Biol. 2010, 48, 545–553. [Google Scholar] [CrossRef]
  27. Mir, P.A.; Mohi-u-Din, R.; Dar, M.A.; Bader, G.N. Anti-inflammatory and anti-helminthic potential of methanolic and aqueous extract of Polygonum alpinum rhizomes. J. Drug Deliv. Ther. 2019, 9, 455–459. [Google Scholar] [CrossRef]
  28. Borchardt, J.R.; Wyse, D.L.; Sheaffer, C.C.; Kauppi, K.L.; Ehlke, N.J.; Biesboer, D.D.; Bey, R.F. Antimicrobial activity of native and naturalized plants of Minnesota and Wisconsin. J. Med. Plants Res. 2008, 2, 98–110. [Google Scholar] [CrossRef]
  29. Smolarz, H.D.; Budzianowski, J.; Bogucka-Kocka, A.; Kocki, J.; Mendyk, E. Flavonoid glucuronides with anti-leukaemic activity from Polygonum amphibium L. Phytochem. Anal. 2008, 19, 506–513. [Google Scholar] [CrossRef]
  30. Tantry, M.A.; Radwan, M.M.; Akbar, S.; Khan, I.A. 5,6-Dihydropyranobenzopyrone: A previously undetermined antioxidant isolated from Polygonum amplexicaule. Chin. J. Nat. Med. 2012, 10, 28–31. [Google Scholar] [CrossRef]
  31. Batool, S.; Gulfraz, M.; Naqvi, S.M.; Mirza, B.; Ahmad, M.S. Evaluation of antioxidant potential and HPLC based identification of phenolics in Polygonum amplexicaule extract and its fractions. Pak. J. Pharm. Sci. 2015, 28, 431–435. [Google Scholar]
  32. Xiang, M.; Su, H.; Hong, Z.; Yang, T.; Shu, G. Chemical composition of total flavonoids from Polygonum amplexicaule and their pro-apoptotic effect on hepatocellular carcinoma cells: Potential roles of suppressing STAT3 signaling. Food Chem. Toxicol. 2015, 80, 62–71. [Google Scholar] [CrossRef]
  33. Xiang, M.; Su, H.; Shu, G.; Wan, D.; He, F.; Loaec, M.; Ding, Y.; Li, J.; Dovat, S.; Yang, G.; et al. Amplexicaule A exerts anti-tumor effects by inducing apoptosis in human breast cancer. Oncotarget 2016, 7, 18521–18530. [Google Scholar] [CrossRef] [Green Version]
  34. Maqsood, F.; Ibrahim, T.; Farooqi, A.A.; Ahmad, M.S. Polygonum amplexicaule extract: An effective herbal cure to CCl. J. Rare Disord. Diagn. Ther. 2017, 3, 4. [Google Scholar] [CrossRef]
  35. Mazid, M.A.; Datta, B.K.; Nahar, L.; Bashar, S.A.M.; Bachar, S.C.; Sarker, S.D. Antinociceptive, anti-inflammatory and diuretic properties of Polygonum barbatum (L.) Hara var. barbata. Rev. Bras. Farmacogn. 2009, 19, 749–754. [Google Scholar] [CrossRef]
  36. Farooq, U.; Naz, S.; Shams, A.; Raza, Y.; Ahmed, A.; Rashid, U.; Sadiq, A. Isolation of dihydrobenzofuran derivatives from ethnomedicinal species Polygonum barbatum as anticancer compounds. Biol. Res. 2019, 52, 1. [Google Scholar] [CrossRef]
  37. Mazid, A.M.; Nahar, L.; Datta, B.K.; Bashar, K.S.; Sarker, S.D. Potential antitumor activity of two Polygonum species. Arch. Biol. Sci. 2011, 63, 465–468. [Google Scholar] [CrossRef]
  38. Kinger, H.K.; Gupta, M.K. Evaluation of anti-ulcer activity of Polygonum barbatum Linn. (whole plant). J. Biomed. Pharmac. Res. 2012, 1, 34–37. [Google Scholar]
  39. Munir, N.; Ijaz, W.; Altaf, I.; Naz, S. Evaluation of antifungal and antioxidant potential of two medicinal plants: Aconitum heterophyllum and Polygonum bistorta. Asian Pac. J. Trop. Biomed. 2014, 4, S639–S643. [Google Scholar] [CrossRef] [Green Version]
  40. Safavi, E.; Homayouni-Tabrizi, M.; Karimi, E.; Mohammad, G.R.K.S. Biosynthesis of zinc oxide nanoparticles using anjbar (root of Persicaria bistorta) extract and their cytotoxic effects on human breast cancer cell line (MCF-7). IET Nanobiotechnol. 2019, 13, 736–741. [Google Scholar] [CrossRef] [PubMed]
  41. Huang, Y.S.H.; Zeng, J.; Ye, H.; Huang, X.; Lai, F. A study on the analgesic effect of Polygonum Bistorta L. n-butyl alcohol. J. Gannan Med. Coll. 2004, 1, 12–13. [Google Scholar]
  42. Intisar, A.; Zhang, L.; Luo, H.; Kiazolu, J.B.; Zhang, R.; Zhang, W. Anticancer constituents and cytotoxic activity of methanol-water extract of Polygonum bistorta L. Afr. J. Tradit. Complement. Altern. Med. 2013, 10, 53–59. [Google Scholar] [CrossRef] [Green Version]
  43. Liu, Y.H.; Weng, Y.P.; Lin, H.Y.; Tang, S.W.; Chen, C.J.; Liang, C.J.; Ku, C.Y.; Lin, J.Y. Aqueous extract of Polygonum bistorta modulates proteostasis by ROS-induced ER stress in human hepatoma cells. Sci. Rep. 2017, 7, 41437. [Google Scholar] [CrossRef] [Green Version]
  44. Pillai Manoharan, K.; Yang, D.; Hsu, A.; Tan Kwong Huat, B. Evaluation of Polygonum bistorta for anticancer potential using selected cancer cell lines. Med. Chem. 2007, 3, 121–126. [Google Scholar] [CrossRef]
  45. Kumar, M.D.; Deepmala, J.; Sangeeta, S. Antioxidant, antipyretic and choleretic activities of crude extract and active compound of Polygonum Bistorta (Linn.) in albino rats. Int. J. Pharm. Bio. Sci. 2012, 2, 25–31. [Google Scholar]
  46. Mittal, D.K.; Joshi, D. Evaluation of DNA damage by comet and mtt-assay in liver treated with Polygonum bistorta and tannic acid. Int. J. Pharm. Bio. Sci. 2012, 3, 375–382. [Google Scholar]
  47. Khushtar, M.; Ahmad, A.; Rahman, M.A. Gastroprotective effect of hydro-alcoholic extract of Polygonum bistorta Lin root in indomethacin-induced gastric ulcers in sprague dawley rats. Indian J. Pharm. Educ. Res. 2018, 52, 618–625. [Google Scholar] [CrossRef] [Green Version]
  48. Liao, S.G.; Zhang, L.J.; Sun, F.; Zhang, J.J.; Chen, A.Y.; Lan, Y.Y.; Dong, L. Antibacterial and anti-inflammatory effects of extracts and fractions from Polygonum capitatum. J. Ethnopharmacol. 2011, 134, 1006–1009. [Google Scholar] [CrossRef]
  49. Lai, S.M.; Sudhahar, D.; Anandarajagopal, K. Evaluation of antibacterial and antifungal activities of Persicaria chinensis leaves. Int. J. Pharm. Sci. Res. 2012, 3, 2825–2830. [Google Scholar] [CrossRef]
  50. Srividya, A.R.; Shalom, A.; Chandrasekhar, R.; Vijayan, P.; Vishnuvarthtan, V.J. Cytotoxic, antioxidant and antimicrobial activity of Polygonum chinensis Linn. Int. J. Pharm. Sci. Nanotechnol. 2012, 4, 1569–1574. [Google Scholar] [CrossRef]
  51. Zhang, H.W.; Wang, Y.; Du, X.W.; Ding, G.; Zou, Z.M. Chemical constituents of whole plant of Polygonum chinese L. var hispidum hook. f. Chin. Pharm. J. 2015, 50, 1012–1016. [Google Scholar]
  52. Wu, Y.; Zhang, Z.; Chen, T.; Cheng, C.; Zhang, Z.; Zhou, H.; Luo, P. Comparison of two Polygonum chinense varieties used in Chinese cool tea in terms of chemical profiles and antioxidant/anti-inflammatory activities. Food Chem. 2020, 310, 125840. [Google Scholar] [CrossRef]
  53. Hossen, M.J.; Baek, K.S.; Kim, E.; Yang, W.S.; Jeong, D.; Kim, J.H.; Kweon, D.H.; Yoon, D.H.; Kim, T.W.; Kim, J.H.; et al. In vivo and in vitro anti-inflammatory activities of Persicaria chinensis methanolic extract targeting Src/Syk/NF-κB. J. Ethnopharmacol. 2015, 159, 9–16. [Google Scholar] [CrossRef] [PubMed]
  54. Chen, W.; Shen, X.; Ma, L.; Chen, R.; Yuan, Q.; Zheng, Y.; Li, C.; Peng, G. Phenolic compounds from Polygonum chinense induce growth inhibition and apoptosis of cervical cancer SiHa cells. BioMed Res. Int. 2020. [CrossRef]
  55. Tran, T.T.; Kim, M.; Jang, Y.; Lee, H.W.; Nguyen, H.T.; Nguyen, T.N.; Park, H.W.; Le Dang, Q.; Kim, J.C. Characterization and mechanisms of anti-influenza virus metabolites isolated from the Vietnamese medicinal plant Polygonum chinense. BMC Complement. Alter. Med. 2014, 17, 162. [Google Scholar] [CrossRef] [Green Version]
  56. Lai, S.M.; Sudhahar, D.; Anandarajagopal, K. In vitro anthelmintic potential of Persicaria chinensis leaves. Int. J. Biol. Pharm. Res. 2012, 3, 400–404. [Google Scholar]
  57. Ismail, I.F.; Golbabapour, S.; Hassandarvish, P.; Hajrezaie, M.; Abdul Majid, N.; Kadir, F.A.; Al-Bayaty, F.; Awang, K.; Hazni, H.; Abdulla, M.A. Gastroprotective activity of Polygonum chinense aqueous leaf extract on ethanol-induced hemorrhagic mucosal lesions in rats. Evid. Based Complement. Alternat. Med. 2012, 2012, 1–9. [Google Scholar] [CrossRef]
  58. Youssef, A.M.M.; El-Swaify, Z.A.S. Anti-Tumour Effect of two Persicaria species seeds on colon and prostate cancers. Biomed. Pharmacol. J. 2018, 11, 635–644. [Google Scholar] [CrossRef]
  59. Zheoat, A.M.; Alenezi, S.; Elmahallawy, E.K.; Ungogo, M.A.; Alghamdi, A.H.; Watson, D.G.; Igoli, J.O.; Gray, A.I.; Koning, H.P.; Ferro, V.A. Antitrypanosomal and antileishmanial activity of chalcones and flavanones from Polygonum salicifolium. Pathogens 2021, 10, 175. [Google Scholar] [CrossRef] [PubMed]
  60. Brandão, G.C.; Kroon, E.G.; Duarte, M.G.R.; Braga, F.C.; de Souza Filho, J.D.; de Oliveira, A.B. Antimicrobial, antiviral and cytotoxic activity of extracts and constituents from Polygonum spectabile Mart. Phytomedicine 2010, 17, 926–929. [Google Scholar] [CrossRef]
  61. Rodrigues, D.F.; Maniscalco, D.A.; Silva, F.A.; Chiari, B.G.; Castelli, M.V.; Isaac, V.L.; Cicarelli, R.M.B.; Lopez, S.N. Trypanocidal activity of flavokawin B, a component of Polygonum ferrugineum Wedd. Planta Med. 2017, 83, 239–244. [Google Scholar] [CrossRef] [PubMed]
  62. Jani, M.; Shah, S.; Prajapati, S. Antibacterial screening and qualitative phytochemical estimation of selected aquatic plants. Adv. Biol. Res. 2012, 6, 19–23. [Google Scholar] [CrossRef]
  63. Said, M.S.; Chinchansure, A.A.; Nawale, L.; Durge, A.; Wadhwani, A.; Kulkarni, S.S.; Sarkar, D.; Joshi, S.P. A new butenolide cinnamate and other biological active chemical constituents from Polygonum glabrum. Nat. Prod. Res. 2015, 29, 2080–2086. [Google Scholar] [CrossRef]
  64. Palani, R.; Karunakaran, D.; Rajesh, V.; Mathivanan, K.; Jayaraman, P. Analysis of antioxidant, antimicrobial activity and phytochemical potential of Cleistanthus collinus Roxb., Polygonum glabrum Wild. and Melia azedarch Linn. Asian J. Med. Pharm. Sci. 2014, 2, 149–159. [Google Scholar]
  65. Rajamanickam, M.; Rajamohan, S. Analgesic activity of flavonoids isolated from Persicaria glabra (wild). Adv. Tradit. Med. 2020, 20, 71–76. [Google Scholar] [CrossRef]
  66. Ali, A.M. Phytochemical and Pharmacological Studies of Selected Sudanese Medicinal Plants with Emphasis on Polygonum glabrum. Ph.D. Thesis, University of Khartoum, Khartoum, Sudan, 2003. [Google Scholar]
  67. Rahman, H.U.; Rehman, T.U.; Ali, A.; Shah, S.A.A.; Ismail, M. In vitro anti-leishmanial activity of Polygonum glabrum stem extract on Leishmania tropica (KWH23) Strain. J. Adv. Biol. Biotechnol. 2015, 3, 23–28. [Google Scholar] [CrossRef]
  68. Jamal, B.D.; Avinash, K.R.G.; Naganjenulu, R.; Jyothi, M.J.; Kalishwari, E.; Anvesh, M. Phytochemical screening and antipyretic activity of root stocks of Polygonum glabrum Willd in rats. Int. J. Pharmacother. 2011, 1, 1–4. [Google Scholar]
  69. Suneesha, Y.; Vinay Kumar, T. Evaluation of anti-alzheimer activity of ethanolic and methanolic extracts of Polygonum Glabrum against Aluminum chloride induced Alzheimer’s in experimental rats. Asian J. Pharm. Clin. Res. 2021, 4, 118–125. [Google Scholar]
  70. Nizar, K.; Sanghamitra, M.; Tiwary, M.P.; Singh, P.N.; Kumar, V. Antidepressant activity and brain neurotransmitters study of Polygonum glabrum Willd in rodents. J. Herb. Med. Toxicol. 2007, 1, 73–79. [Google Scholar]
  71. Duraipandiyan, V.; Indwar, F.; Ignacimuthu, S. Antimicrobial activity of confertifolin from Polygonum hydropiper. Pharm. Biol. 2010, 48, 187–190. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Hasan, M.F.; Das, R.; Khan, A.; Hossain, M.S.; Rahman, M. The determination of antibacterial and antifungal activities of Polygonum hydropiper (L.) root extract. Adv. Biol. Res. 2009, 3, 53–56. [Google Scholar]
  73. Lee, S.H.; Lee, J.R.; Lunde, C.S.; Kubo, I. In vitro antifungal susceptibilities of Candida albicans and other fungal pathogens to polygodial, a sesquiterpene dialdehyde. Planta Med. 1999, 65, 204–208. [Google Scholar] [CrossRef] [PubMed]
  74. Ayaz, M.; Junaid, M.; Ullah, F.; Sadiq, A.; Shahid, M.; Ahmad, W.; Ullah, I.; Ahmad, A.; Syed, N.I.H. GC-MS analysis and gastroprotective evaluations of crude extracts, isolated saponins, and essential oil from Polygonum hydropiper L. Front. Chem. 2017, 5, 1–11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Nasir, A.; Khan, M.; Rehman, Z.; Khalil, A.A.K.; Farman, S.; Begum, N.; Irfan, M.; Sajjad, W.; Parveen, Z. Evaluation of alpha-amylase inhibitory, antioxidant, and antimicrobial potential and phytochemical contents of Polygonum hydropiper L. Plants 2020, 9, 852. [Google Scholar] [CrossRef] [PubMed]
  76. Hashim, N.H.N.; Abas, F.; Shaari, K.; Lajis, N.H. LC–DAD–ESIMS/MS characterization of antioxidant and anticholinesterase constituents present in the active fraction from Persicaria hydropiper. LWT-Food Sci. Technol. 2012, 46, 468–476. [Google Scholar] [CrossRef]
  77. Peng, Z.F.; Strack, D.; Baumert, A.; Subramaniam, R.; Goh, N.K.; Chia, T.F.; Tan, S.N.; Chia, L.S. Antioxidant flavonoids from leaves of Polygonum hydropiper L. Phytochemistry 2003, 62, 219–228. [Google Scholar] [CrossRef]
  78. Ayaz, M.; Junaid, M.; Ullah, F.; Sadiq, A.; Khan, M.A.; Ahmad, W.; Shah, M.R.; Imran, M.; Ahmad, S. Comparative chemical profiling, cholinesterase inhibitions and anti-radicals’ properties of essential oils from Polygonum hydropiper L: A Preliminary anti-Alzheimer’s study. Lipids Health Dis. 2015, 14, 1–12. [Google Scholar] [CrossRef] [Green Version]
  79. Yang, Y.; Yu, T.; Jang, H.J.; Byeon, S.E.; Song, S.Y.; Lee, B.H.; Rhee, M.H.; Kim, T.W.; Lee, J.; Hong, S.; et al. In vitro and in vivo anti-inflammatory activities of Polygonum hydropiper methanol extract. J. Ethnopharmacol. 2012, 139, 616–625. [Google Scholar] [CrossRef]
  80. Zhang, W.; Pan, Y.; Qu, S.; Wang, D.; Cheng, S.; Liu, X. Anti-inflammatory effects of an extract of Polygonum hydropiper stalks on 2, 4, 6-trinitrobenzenesulphonic acid-induced intestinal inflammation in rats by inhibiting the NF-κB pathway. Mediat. Inflamm. 2018, 2018. [Google Scholar] [CrossRef]
  81. Rahman, E.; Goni, S.A.; Rahman, M.T.; Ahmed, M. Antinociceptive activity of Polygonum hydropiper. Fitoterapia 2002, 73, 704–706. [Google Scholar] [CrossRef]
  82. Oany, A.R.; Hossain, M.U.; Islam, R.; Emran, A.A. A preliminary evaluation of cytotoxicity, antihyperglycemic and antinociceptive activity of Polygonum hydropiper L. ethanolic leaf extract. Clin. Phytosci. 2017, 2, 2. [Google Scholar] [CrossRef] [Green Version]
  83. Ayaz, M.; Junaid, M.; Ullah, F.; Sadiq, A.; Subhan, F.; Khan, M.A.; Ahmad, W.; Ali, G.; Imran, M.; Ahmad, S. Molecularly characterized solvent extracts and saponins from Polygonum hydropiper L. show high anti-angiogenic, anti-tumor, brine shrimp, and fibroblast NIH/3T3 cell line cytotoxicity. Front. Pharmacol. 2016, 7, 74. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Ayaz, M.; Sadiq, A.; Wadood, A.; Junaid, M.; Ullah, F.; Khan, N.Z. Cytotoxicity and molecular docking studies on phytosterols isolated from Polygonum hydropiper L. Steroids 2019, 141, 30–35. [Google Scholar] [CrossRef] [PubMed]
  85. Raihan, M.O.; Khalequeuzzaman, M.; Brishti, A.; Tareq, S.M.; Hossain, A.; Rana, S. Anthelmintic and antiproliferative activity of aerial parts of Persicaria hydropiper. Der Pharm. Sin. 2012, 3, 104–110. [Google Scholar]
  86. Munira, S.; Sultana, F.; Mollika, S.; Nesa, L.; Ria, J.; Islam, M.M. Anti-neoplastic activities of Polygonum hydropiper Linn. against ehrlich ascites carcinoma in Swiss Albino mice. Adv. Biol. Res. 2013, 7, 9–14. [Google Scholar] [CrossRef]
  87. Xiao, H.; Rao Ravu, R.; Tekwani, B.L.; Li, W.; Liu, W.B.; Jacob, M.R.; Khan, S.I.; Cai, X.; Peng, C.Y.; Khan, I.A.; et al. Biological evaluation of phytoconstituents from Polygonum hydropiper. Nat. Prod. Res. 2017, 31, 2053–2057. [Google Scholar] [CrossRef]
  88. Ayaz, M.; Junaid, M.; Subhan, F.; Ullah, F.; Sadiq, A.; Ahmad, S.; Imran, M.; Kamal, Z.; Hussain, S.; Shah, S.M. Heavy metals analysis, phytochemical, phytotoxic and anthelmintic investigations of crude methanolic extract, subsequent fractions and crude saponins from Polygonum hydropiper L. BMC Complement. Alter. Med. 2014, 14, 465. [Google Scholar] [CrossRef] [Green Version]
  89. Akhter, R.; Haque, M.A.; Bhuiyan, M.A.; Shahriar, M. In vivo Pharmacological investigation of leaf of Polygonum hydropiper (L.). Dhaka Univ. J. Pharm. Sci. 2013, 12, 165–169. [Google Scholar] [CrossRef]
  90. Ayaz, M.; Junaid, M.; Ullah, F.; Subhan, F.; Sadiq, A.; Ali, G.; Ovais, M.; Shahid, M.; Ahmad, A.; Wadood, A.; et al. Anti-Alzheimer’s studies on β-sitosterol isolated from Polygonum hydropiper L. Front. Pharmacol. 2017, 8, 697. [Google Scholar] [CrossRef] [Green Version]
  91. Sharif, S.; Shahriar, M.; Haque, M.A.; Chowdhury, Z.S.; Islam, M.R.; Bhuiyan, M.A. In-vitro antioxidant activities, anti-nociceptive and neuropharmacological activities of Polygonum hydropiper. J. Biol. Agric. Healthc. 2013, 3, 61–71. [Google Scholar]
  92. Devarajan, S.; Yahiro, E.; Uehara, Y.; Kuroda, R.; Hirano, Y.; Nagata, K.; Miura, S.; Saku, K.; Urata, H. Depressor effect of the young leaves of Polygonum hydropiper Linn. in high-salt induced hypertensive mice. Biomed. Pharmacother. 2018, 102, 1182–1187. [Google Scholar] [CrossRef] [PubMed]
  93. Shahed-Al-Mahmud, M.; Lina, S.M.M. Evaluation of sedative and anxiolytic activities of methanol extract of leaves of Persicaria hydropiper in mice. Clin. Phytosci. 2017, 3, 20. [Google Scholar] [CrossRef] [Green Version]
  94. Bussmann, R.W.; Glenn, A.; Sharon, D. Antibacterial activity of medicinal plants of Northern Peru–can traditional applications provide leads for modern science. Indian J. Tradit. Knowl. 2010, 9, 742–753. [Google Scholar]
  95. Braga, F.G.; Bouzada, M.L.M.; Fabri, R.L.; Matos, M.D.O.; Moreira, F.O.; Scio, E.; Coimbra, E.S. Antileishmanial and antifungal activity of plants used in traditional medicine in Brazil. J. Ethnopharmacol. 2007, 111, 396–402. [Google Scholar] [CrossRef]
  96. Hailemariam, A.; Feyera, M.; Deyou, T.; Abdissa, N. Antimicrobial Chalcones from the Seeds of Persicaria lapathifolia. Biochem. Pharmacol. 2018, 7, 2167-0501. [Google Scholar] [CrossRef]
  97. Kubinova, R.; Pořízková, R.; Bartl, T.; Navratilova, A.; Cížek, A.; Valentova, M. Biological activities of polyphenols from Polygonum lapathifolium. Bol. Latinoam. Caribe Plantas Med. Aromát. 2014, 13, 506–516. [Google Scholar]
  98. Saha, A.; Chowdhury, K.K.; Bachar, S.C.; Roy, S.C.; Kundu, J.K. Anti-inflammatory, analgesic and diuretic activity of Polygonum lanatum Roxb. Pak. J. Pharm. Sc. 2005, 18, 13–18. [Google Scholar]
  99. Smolarz, H.D.; Mendyk, E.; Bogucka-Kocka, A.; Kockic, J. Pinostrobin–an anti-leukemic flavonoid from Polygonum lapathifolium L. ssp. nodosum (Pers.) Dans. Z. Naturforsch. C 2006, 61, 64–68. [Google Scholar] [CrossRef] [Green Version]
  100. Takasaki, M.; Konoshima, T.; Kuroki, S.; Tokuda, H.; Nishino, H. Cancer chemopreventive activity of phenylpropanoid esters of sucrose, vanicoside B and lapathoside A, from Polygonum lapathifolium. Cancer Lett. 2001, 173, 133–138. [Google Scholar] [CrossRef]
  101. Bulbul, L.; Sushanta, S.M.; Uddin, M.J.; Tanni, S. Phytochemical and pharmacological evaluations of Polygonum lapathifolium stem extract for anthelmintic and antiemetic activity. Int. Curr. Pharm. J. 2013, 2, 57–62. [Google Scholar] [CrossRef] [Green Version]
  102. Dzoyem, J.P.; Nkuete, A.H.; Kuete, V.; Tala, M.F.; Wabo, H.K.; Guru, S.K.; Rajput, V.S.; Sharma, A.; Tane, P.; Khan, I.A.; et al. Cytotoxicity and antimicrobial activity of the methanol extract and compounds from Polygonum limbatum. Planta Med. 2012, 78, 787–792. [Google Scholar] [CrossRef] [Green Version]
  103. Kuete, V.; Nkuete, A.H.; Mbaveng, A.T.; Wiench, B.; Wabo, H.K.; Tane, P.; Efferth, T. Cytotoxicity and modes of action of 4′-hydroxy-2′, 6′-dimethoxychalcone and other flavonoids toward drug-sensitive and multidrug-resistant cancer cell lines. Phytomedicine 2014, 21, 1651–1657. [Google Scholar] [CrossRef] [PubMed]
  104. Smolarz, H.D.; Kosikowska, U.; Baraniak, B.; Malm, A.; Persona, A. Lipophilicity, antifungal and antioxidant properties of persilben. Acta Pol. Pharm. 2005, 62, 457–460. [Google Scholar] [CrossRef]
  105. Hussain, F.; Ahmad, B.; Hameed, I.; Dastagir, G.; Sanaullah, P.; Azam, S. Antibacterial, antifungal and insecticidal activities of some selected medicinal plants of Polygonaceae. Afr. J. Biotechnol. 2010, 9, 5032–5036. [Google Scholar]
  106. Jovanović, M.; Morić, I.; Nikolić, B.; Pavić, A.; Svirčev, E.; Šenerović, L.; Mitić-Ćulafić, D. Anti-virulence potential and in vivo toxicity of Persicaria maculosa and Bistorta officinalis extracts. Molecules 2020, 25, 1811. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  107. Quesada-Romero, L.; Fernández-Galleguillos, C.; Bergmann, J.; Amorós, M.E.; Jiménez-Aspee, F.; González, A.; Simirgiotis, M.; Rossini, C. Phenolic fingerprinting, antioxidant, and deterrent potentials of Persicaria maculosa Extracts. Molecules 2020, 25, 3054. [Google Scholar] [CrossRef] [PubMed]
  108. Hussein, S.R.; Mohamed, A.A. Antioxidant activity and phenolic profiling of two Egyptian medicinal herbs Polygonum salicifolium Brouss ex Wild and Polygonum senegalense Meisn. Ann. Univ. Oradea Fasc. Biol. 2013, 20, 59–63. [Google Scholar]
  109. Lajter, I.; Vasas, A.; Orvos, P.; Bánsághi, S.; Tálosi, L.; Jakab, G.; Béni, Z.; Háda, V.; Forgo, P.; Hohmann, J. Inhibition of G protein-activated inwardly rectifying K+ channels by extracts of Polygonum persicaria and isolation of new flavonoids from the chloroform extract of the herb. Planta Med. 2013, 79, 1736–1741. [Google Scholar] [CrossRef]
  110. Hassim, N.; Markom, M.; Anuar, N.; Baharum, S.N. Solvent selection in extraction of essential oil and bioactive compounds from Polygonum minus. J. Appl. Sci. 2014, 14, 1440–1444. [Google Scholar] [CrossRef] [Green Version]
  111. Uyub, A.M.; Nwachukwu, I.N.; Azlan, A.A.; Fariza, S.S. In-vitro antibacterial activity and cytotoxicity of selected medicinal plant extracts from Penang Island Malaysia on metronidazole-resistant-Helicobacter pylori and some pathogenic bacteria. Ethnobot. Res. Appl. 2010, 8, 95–106. [Google Scholar] [CrossRef] [Green Version]
  112. Abubakar, M.A.; Zulkifli, R.M.; Hassan, W.N.; Shariff, A.H.M.; Malek, N.Á.; Zakaria, Z.; Ahmad, F. Antibacterial properties of Persicaria minor (Huds.) ethanolic and aqueous-ethanolic leaf extracts. J. Appl. Pharm. Sci. 2015, 5, 50–56. [Google Scholar] [CrossRef]
  113. Ahmad, R.; Baharum, S.N.; Bunawan, H.; Lee, M.; Mohd Noor, N.; Rohani, E.R.; Zin, N.M. Volatile profiling of aromatic traditional medicinal plant, Polygonum minus in different tissues and its biological activities. Molecules 2014, 19, 19220–19242. [Google Scholar] [CrossRef] [Green Version]
  114. Qader, S.W.; Abdulla, M.A.; Chua, L.S.; Najim, N.; Zain, M.M.; Hamdan, S. Antioxidant, total phenolic content and cytotoxicity evaluation of selected Malaysian plants. Molecules 2011, 16, 3433–3443. [Google Scholar] [CrossRef] [PubMed]
  115. George, A.; Chinnappan, S.; Chintamaneni, M.; Kotak, V.; Choudhary, Y.; Kueper, T.; Radhakrishnan, A.K. Anti-inflammatory effects of Polygonum minus (Huds) extract (Lineminus™) in in-vitro enzyme assays and carrageenan induced paw edema. BMC Complement. Alter. Med. 2014, 14, 335. [Google Scholar] [CrossRef] [Green Version]
  116. Rohin, M.A.K.; Abd Hadi, N.; Ridzwan, N. Different polarity Extracts of Polygonum minus towards cytotoxic activities against colon cancer cell lines (HT-29, HCT-116, CT-26). J. Pharm. Res. Int. 2020, 32, 168–180. [Google Scholar] [CrossRef]
  117. Ahmad, R.; Sahidin, I.; Taher, M.; Low, C.; Noor, N.M.; Sillapachaiyaporn, C.; Chuchawankul, S.; Sarachana, T.; Tencomnao, T.; Iskandar, F.; et al. Polygonumins A, a newly isolated compound from the stem of Polygonum minus Huds with potential medicinal activities. Sci. Rep. 2018, 8, 4202. [Google Scholar] [CrossRef] [PubMed]
  118. Hamidi, J.A.; Ismaili, N.H.; Ahmadi, F.B.; Lajisi, N.H. Antiviral and cytotoxic activities of some plants used in Malaysian indigenous medicine. Pertanika J. Trop. Agric. Sci. 1996, 19, 129–136. [Google Scholar]
  119. Christapher, P.V.; Joe, L.S.; Tian, M.; Mohan, T.S.B.; Parasuraman, S.; Al-Suede, F.S.R.; Murugaiyah, V. Evaluation of methanol extract of Polygonum minus Huds. leaves for its hepatoprotective activity. Malays. J. Microbiol. 2016, 12, 345–352. [Google Scholar]
  120. Basha, D.J.; Joy, J.M.; Kumar, A.S.; Kumar Reddy, G.A.; Dalith, M.D. Hepatoprotective activity of root stocks of Polygonum glabrum Willd. Family Polygonaceae. Int. J. Phytopharm. Res. 2011, 2, 22–29. [Google Scholar]
  121. George, A.; Ng, C.P.; O’Callaghan, M.; Jensen, G.S.; Wong, H.J. In vitro and ex-vivo cellular antioxidant protection and cognitive enhancing effects of an extract of Polygonum minus Huds (Lineminus™) demonstrated in a Barnes Maze animal model for memory and learning. BMC Complement. Alter. Med. 2014, 14, 161. [Google Scholar] [CrossRef] [Green Version]
  122. Wasman, S.Q.; Mahmood, A.A.; Salehhuddin, H.; Zahra, A.A.; Salmah, I. Cytoprotective activities of Polygonum minus aqueous leaf extract on ethanol-induced gastric ulcer in rats. J. Med. Plants Res. 2010, 4, 2658–2665. [Google Scholar] [CrossRef]
  123. Qader, S.W.; Abdulla, M.A.; Chua, L.S.; Sirat, H.M.; Hamdan, S. Pharmacological mechanisms underlying gastroprotective activities of the fractions obtained from Polygonum minus in Sprague Dawley rats. Int. J. Mol. Sci. 2012, 13, 1481–1496. [Google Scholar] [CrossRef] [PubMed]
  124. George, A.; Chinnappan, S.; Choudhary, Y.; Bommu, P.; Sridhar, M. Immunomodulatory activity of an aqueous extract of Polygonum minus Huds on Swiss albino mice using carbon clearance assay. Asian Pac. J. Trop. Dis. 2014, 4, 398–400. [Google Scholar] [CrossRef]
  125. Wei, Y.; Chen, X.; Jiang, X.; Ma, Z.; Xiao, J. Determination of taxifolin in Polygonum orientale and study on its antioxidant activity. J. Food Compos. Anal. 2009, 22, 154–157. [Google Scholar] [CrossRef]
  126. Ansari, P.; Uddin, M.J.; Rahman, M.M.; Abdullah-Al-Mamun, M.; Islam, M.R.; Ali, M.H.; Reza, A.A. Anti-inflammatory, anti-diarrheal, thrombolytic and cytotoxic activities of an ornamental medicinal plant: Persicaria orientalis. J. Basic Clin. Physiol. Pharm. 2017, 28, 51–58. [Google Scholar] [CrossRef]
  127. Gou, K.J.; Zeng, R.; Dong, Y.; Hu, Q.Q.; Hu, H.W.Y.; Maffucci, K.G.; Dou, Q.L.; Yang, Q.B.; Qin, X.H.; Qu, Y. Anti-inflammatory and analgesic effects of Polygonum orientale L. extracts. Front. Pharm. 2017, 8, 562. [Google Scholar] [CrossRef]
  128. Tong, M.M.; Zhang, Y.Y.; Chu, Z.Y.; Zhai, Y.J. Research on antumor effect in vitro of flowers of Polygonum orientale L. Chinese J. Ethnomed. Ethnopharm. 2013, 24, 7–8. [Google Scholar]
  129. Xie, Z.T.; Tian, L.Q. Study on antitumor activity in vitro of Polygonum orientale L. total extraction and its chemical fractions. Zhong Yi Xue Bao 2012, 27, 1550–1551. [Google Scholar]
  130. Nigam, V. Antihyperglycaemic activity on flower of Polygonum orientale Linn. using steptozotocin induced diabetic mice model. Int. J. Pharm. Teach. Pract. 2013, 4, 759–764. [Google Scholar]
  131. Chiu, Y.J.; Chou, S.C.; Chiu, C.S.; Kao, C.P.; Wu, K.C.; Chen, C.J.; Tsai, J.C.; Peng, W.H. Hepatoprotective effect of the ethanol extract of Polygonum orientale on carbon tetrachloride-induced acute liver injury in mice. J. Food Drug Anal. 2018, 26, 369–379. [Google Scholar] [CrossRef] [Green Version]
  132. Fan, X.; Bai, J.; Hu, M.; Xu, Y.; Zhao, S.; Sun, Y.; Wang, B.; Hu, J.; Li, Y. Drug interaction study of flavonoids toward OATP1B1 and their 3D structure activity relationship analysis for predicting hepatoprotective effects. Toxicology 2020, 437, 152445. [Google Scholar] [CrossRef] [PubMed]
  133. Qi, S.; Feng, Z.; Li, Q.; Qi, Z.; Zhang, Y. Inhibition of ROS-mediated activation Src-MAPK/AKT signaling by orientin alleviates H2O2-induced apoptosis in PC12 cells. Drug Des. Devel. Ther. 2018, 12, 3973–3984. [Google Scholar] [CrossRef] [Green Version]
  134. Do, N.H.; Le, T.M.; Nguyen, C.D.; Ha, A.C. Optimization of total flavonoid content of ethanolic extract of Persicaria pulchra (Bl.) Soják for the inhibition of α-glucosidase enzyme. Fine Chem. Technol. 2020, 15, 39–50. [Google Scholar] [CrossRef]
  135. Nguyen, H.N.; Van Vo, G.; Tran, H.; Ho, H.T.C. Hepatoprotective effect of isolated constituent from Polygonum tomentosum against carbon tetrachloride induced toxicity. Sci. Technol. Dev. J. 2012, 15, 78–86. [Google Scholar] [CrossRef]
  136. Alves, T.M.D.A.; Ribeiro, F.L.; Kloos, H.; Zani, C.L. Polygodial, the fungitoxic component from the Brazilian medicinal plant Polygonum punctatum. Mem. Inst. Oswaldo Cruz 2001, 96, 831–833. [Google Scholar] [CrossRef] [Green Version]
  137. Penna, C.; Marino, S.; Vivot, E.; Cruañes, M.C.; Muñoz, J.D.D.; Cruañes, J.; Ferraro, G.; Martino, V. Antimicrobial activity of Argentine plants used in the treatment of infectious diseases. Isolation of active compounds from Sebastiania brasiliensis. J. Ethnopharmacol. 2001, 77, 37–40. [Google Scholar] [CrossRef]
  138. Lopez, A.; Hudson, J.B.; Towers, G.H.N. Antiviral and antimicrobial activities of Colombian medicinal plants. J. Ethnopharmacol. 2001, 77, 189–196. [Google Scholar] [CrossRef]
  139. Gilabert, M.; Cartagena, E.; Escobar, G.; Bardón, A.; Arena, M. Volatile terpenoids from water pepper (Polygonum punctatum) against Pseudomonas aeruginosa and Staphylococcus aureus virulence strategies. Glob. J. Agric. Innov. Res. Dev. 2014, 1, 3–10. [Google Scholar] [CrossRef]
  140. Oliveira-Simoes, C.M.; Ribeiro-do-Vale, R.M.; Poli, A.; Nicolau, M.; Zanin, M. Pharmacological investigation on Polygonum punctatum Elliott (= P. acre HBK) extracts. J. Pharm. 1989, 44, 275–284. [Google Scholar]
  141. Kott, V.; Barbini, L.; Cruanes, M.; de D Munoz, J.; Vivot, E.; Cruañes, J.; Martino, V.; Ferraro, G.; Cavallaro, L.; Campos, R. Antiviral activity in Argentine medicinal plants. J. Ethnopharmacol. 1998, 64, 79–84. [Google Scholar] [CrossRef]
  142. Sahidin, I.; Bahrun, A.; Taufik, M.; Mahatva Yodha, A.W.; Sabandar, C.W.; Imran, I.; Kadidae, L.O.; Darmawan, A.; Widodo, H.; Diantini, A. Chemical constituents of Persicaria sagittata (L.) H. Gross: Antioxidant activity and chemotaxonomy significance. Jundishapur J. Nat. Pharm. Prod. 2020, 15, e64788. [Google Scholar] [CrossRef]
  143. Kenanda, E.O.; Omosa, L.K. Semi-Synthetic Pyrazoline Derivatives from Polygonum senegalense Chalcones and their Anti-Microbial Activities. Pharmacog. Commn. 2017, 7, 53–60. [Google Scholar] [CrossRef] [Green Version]
  144. Bothon, F.T.; Debiton, E.; Avlessi, F.; Forestier, C.; Teulade, J.C.; Sohounhloue, D.K. In vitro biological effects of two anti-diabetic medicinal plants used in Benin as folk medicine. BMC Complement. Altern. Med. 2013, 13, 51. [Google Scholar] [CrossRef]
  145. Mazid, M.A.; Datta, B.K.; Bachar, S.C.; Bashar, S.K.; Nahar, L.; Sarker, S.D. Analgesic and anti-inflammatory activities of Polygonum stagninum. Pharm. Biol. 2010, 48, 770–774. [Google Scholar] [CrossRef] [PubMed]
  146. Iwaki, K.; Koya-Miyata, S.; Kohno, K.; Ushio, S.; Fukuda, S. Antimicrobial activity of Polygonum tinctorium Lour: Extract against oral pathogenic bacteria. J. Nat. Med. 2006, 60, 121–125. [Google Scholar] [CrossRef]
  147. Kataoka, M.; Hirata, K.; Kunikata, T.; Ushio, S.; Iwaki, K.; Ohashi, K.; Ikeda, M.; Kurimoto, M. Antibacterial action of tryptanthrin and kaempferol, isolated from the indigo plant (Polygonum tinctorium Lour.), against Helicobacter pylori-infected Mongolian gerbils. J. Gastroenterol. 2001, 36, 5–9. [Google Scholar] [CrossRef]
  148. Tokuyama-Nakai, S.; Kimura, H.; Ishihara, T.; Jisaka, M.; Yokota, K. In Vitro anti-inflammatory and antioxidant activities of 3,5,4′-trihydroxy-6,7-methylenedioxyflavone-O-glycosides and their aglycone from leaves of Polygonum tinctorium Lour. Appl. Biochem. Biotechnol. 2018, 184, 414–431. [Google Scholar] [CrossRef]
  149. Kim, S.J.; Jang, T.W.; Kim, D.W.; Park, J.H. Study on antioxidant and anti-inflammatory activities of Persicaria tinctoria. Korea J. Herbol. 2015, 30, 17–24. [Google Scholar] [CrossRef]
  150. Heo, B.G.; Park, Y.J.; Park, Y.S.; Bae, J.H.; Cho, J.Y.; Park, K.; Jastrzebski, Z.; Gorinstein, S. Anticancer and antioxidant effects of extracts from different parts of indigo plant. Ind. Crops Prod. 2014, 56, 9–16. [Google Scholar] [CrossRef]
  151. Lee, S.; Kim, D.C.; Baek, H.Y.; Lee, K.D.; Kim, Y.C.; Oh, H. Anti-neuroinflammatory effects of tryptanthrin from Polygonum tinctorium Lour. in lipopolysaccharide-stimulated BV2 microglial cells. Arch. Pharm. Res. 2018, 41, 419–430. [Google Scholar] [CrossRef] [PubMed]
  152. Kimoto, T.; Hino, K.; Koya-Miyata, S.; Yamamoto, Y.; Takeuchi, M.; Nishizaki, Y.; Micallef, M.J.; Ushio, S.; Iwaki, K.; Ikeda, M.; et al. Cell differentiation and apoptosis of monocytic and promyelocytic leukemia cells (U-937 and HL-60) by tryptanthrin, an active ingredient of Polygonum tinctorium Lour. Pathol. Int. 2001, 51, 315–325. [Google Scholar] [CrossRef] [PubMed]
  153. Tatefuji, T.; Aga, M.; Kunikata, T.; Ikeda, M.; Kurimoto, M. Antiviral effect of Polygonum tinctorium Lour. extracts on virus-infected cells. Nat. Med. 1999, 53, 297–301. [Google Scholar]
  154. Zhong, Y.; Yoshinaka, Y.; Takeda, T.; Shimizu, N.; Yoshizaki, S.; Inagaki, Y.; Matsuda, S.; Honda, G.; Fujii, N.; Yamamoto, N. Highly potent anti-HIV-1 activity isolated from fermented Polygonum tinctorium Aiton. Antiviral Res. 2005, 66, 119–128. [Google Scholar] [CrossRef] [PubMed]
  155. Kimura, H.; Tokuyama, S.; Ishihara, T.; Ogawa, S.; Yokota, K. Identification of new flavonol O-glycosides from indigo (Polygonum tinctorium Lour) leaves and their inhibitory activity against 3-hydroxy-3-methylglutaryl-CoA reductase. J. Pharm. Biomed. Anal. 2015, 108, 102–112. [Google Scholar] [CrossRef]
  156. Cheng, H.W.; Lee, K.C.; Cheah, K.P.; Chang, M.L.; Lin, C.W.; Li, J.S.; Yu, W.Y.; Liu, E.T.; Hu, C.M. Polygonum viviparum L. inhibits the lipopolysaccharide-induced inflammatory response in RAW264. 7 macrophages through haem oxygenase-1 induction and activation of the Nrf2 pathway. J. Sci. Food Agric. 2013, 93, 491–497. [Google Scholar] [CrossRef]
  157. Ceylan, S.; Cetin, S.; Camadan, Y.; Saral, O.; Ozsen, O.; Tutus, A. Antibacterial and antioxidant activities of traditional medicinal plants from the Erzurum region of Turkey. Iran. J. Med. Sci. 2019, 188, 1303–1309. [Google Scholar] [CrossRef]
  158. Salama, H.M.; Marraiki, N. Antimicrobial activity and phytochemical analyses of Polygonum aviculare L. (Polygonaceae), naturally growing in Egypt. Saudi J. Biol. Sci. 2010, 17, 57–63. [Google Scholar] [CrossRef] [Green Version]
  159. Zhang, L.; Ravipati, A.S.; Koyyalamudi, S.R.; Jeong, S.C.; Reddy, N.; Bartlett, J.; Smith, P.; de la Cruz, M.; Monteiro, M.C.; Melguizo, A.; et al. Anti-fungal and anti-bacterial activities of ethanol extracts of selected traditional Chinese medicinal herbs. Asian Pac. J. Trop. Med. 2013, 6, 673–681. [Google Scholar] [CrossRef] [Green Version]
  160. Hsu, C.Y. Antioxidant activity of extract from Polygonum aviculare L. Biol. Res. 2006, 39, 281–288. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  161. Habibi, R.M.; Mohammadi, R.A.; Delazar, A.; Halabian, R.; Soleimani, R.J.; Mehdipour, A.; Bagheri, M.; Jahanian-Najafabadi, A. Effects of Polygonum aviculare herbal extract on proliferation and apoptotic gene expression of MCF-7. J. Ethnopharmacol. 2011, 19, 326–331. [Google Scholar]
  162. Mohammad, R.; Hossein, B.; Davood, F.; Farnaz, T.; Ali, F.; Yusef, R. The apoptotic and cytotoxic effects of Polygonum avicular extract on Hela-S cervical cancer cell line. Afr. J. Biochem. Res. 2011, 5, 373–378. [Google Scholar] [CrossRef]
  163. Cai, Y.; Wu, L.; Lin, X.; Hu, X.; Wang, L. Phenolic profiles and screening of potential α-glucosidase inhibitors from Polygonum aviculare L. leaves using ultra-filtration combined with HPLC-ESI-qTOF-MS/MS and molecular docking analysis. Ind. Crops Prod. 2020, 154, 112,673. [Google Scholar] [CrossRef]
  164. Won, J.B.; Ma, C.J. Neuroprotective activities of some medicinal plants against glutamate-induced neurotoxicity in primary cultures of rat cortical cells. Nat. Prod. Sci. 2009, 15, 125–129. [Google Scholar]
  165. Zhang, F.X.; Xu, R.S. Juglanin ameliorates LPS-induced neuroinflammation in animal models of Parkinson’s disease and cell culture via inactivating TLR4/NF-κB pathway. Biomed. Pharmacother. 2018, 97, 1011–1019. [Google Scholar] [CrossRef]
  166. Park, S.H.; Jang, S.; Son, E.; Lee, S.W.; Park, S.D.; Sung, Y.Y.; Kim, H.K. Polygonum aviculare L. extract reduces fatigue by inhibiting neuroinflammation in restraint-stressed mice. Phytomedicine 2018, 42, 180–189. [Google Scholar] [CrossRef]
  167. El-Kader, A.; Adel, M.; Nafady, A.M.; Ahmed, A.S.; Ibraheim, Z.Z. Antioxidant, hepatoprotective and antimicrobial activities of the aerial parts of Polygonum bellardii All. Bull. Pharm. Sci. Assiut. 2012, 35, 43–53. [Google Scholar] [CrossRef] [Green Version]
  168. Abd El-Kader, A.M.; El-Readi, M.Z.; Ahmed, A.S.; Nafady, A.M.; Wink, M.; Ibraheim, Z.Z. Polyphenols from aerial parts of Polygonum bellardii and their biological activities. Pharm. Biol. 2013, 51, 1026–1034. [Google Scholar] [CrossRef] [PubMed]
  169. Eruygur, N.; Ucar, E.; Ataş, M.; Ergul, M.; Ergul, M.; Sozmen, F. Determination of biological activity of Tragopogon porrifolius and Polygonum cognatum consumed intensively by people in Sivas. Toxicol. Rep. 2020, 7, 59–66. [Google Scholar] [CrossRef]
  170. Pekdemir, M.E.; Pekdemir, S.; İnci, Ş.; Kırbağ, S.; Çiftci, M. Thermal, magnetic properties and antimicrobial effects of magnetic iron oxide nanoparticles treated with Polygonum cognatum. Iran. J. Sci. Technol. 2021. [CrossRef]
  171. Mahmoudi, M.; Boughalleb, F.; Mabrouk, M.; Tlili, N.; Potter, D.; Abdellaoui, R.; Nasri, N. Chemical analysis of the antioxidants from the aerial parts of wild Polygonum equisetiforme from Tunisia. Food Biosci. 2019, 29, 24–29. [Google Scholar] [CrossRef]
  172. El-Toumy, S.A.H.; Salib, J.Y.; Shafik, N.H.; Elkarim, A.S.A.; Salama, A.; Omara, E.A.A.; Micky, J. Evaluation of hepatoprotective activity of Polygonum equisetiforme methanolic extract. J. Appl. Pharm. Sci. 2019, 9, 54–59. [Google Scholar] [CrossRef] [Green Version]
  173. Zhang, C.F.; Hu, Y.; Lin, Y.; Huang, F.; Zhang, M. Anti-inflammatory activities of ethyl acetate extract of Polygonum jucundum and its phytochemical study. J. Med. Plants Res. 2012, 6, 1505–1511. [Google Scholar] [CrossRef]
  174. Jovanović, M.; Srdić-Rajić, T.; Svirčev, E.; Jasnić, N.; Nikolić, B.; Bojić, S.; Stević, T.; Knežević-Vukčević, J.; Mitić-Ćulafić, D. Evaluation of anticancer and antimicrobial activities of the Polygonum maritimum ethanol extract. Arch. Biol. Sci. 2018, 70, 665–673. [Google Scholar] [CrossRef] [Green Version]
  175. El-Haci, I.A.; Bekkara, F.A.; Mazari, W.; Hassani, F.; Didi, M.A. Screening of biological activities of Polygonum maritimum L. from Algerian coast. Asian Pac. J. Trop. Biomed. 2013, 3, 611–616. [Google Scholar] [CrossRef] [Green Version]
  176. Rodrigues, M.J.; Matkowski, A.; Ślusarczyk, S.; Magne, C.; Poleze, T.; Pereira, C.; Custodio, L. Sea knotgrass (Polygonum maritimum L.) as a potential source of innovative industrial products for skincare applications. Ind. Crops Prod. 2019, 128, 391–398. [Google Scholar] [CrossRef]
  177. Rodrigues, M.J.; Custódio, L.; Lopes, A.; Oliveira, M.; Neng, N.R.; Nogueira, J.M.; Martins, A.; Rauter, A.P.; Varela, J.; Barreira, L. Unlocking the in vitro anti-inflammatory and antidiabetic potential of Polygonum maritimum. Pharm. Biol. 2017, 55, 1348–1357. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  178. Rodrigues, M.J.; Varela, J.; Barreira, L.; Custódio, L. Antioxidant and neuroprotective potential of two halophytes from the Algarve coast. Planta Med. 2014, 80, P2Y16. [Google Scholar] [CrossRef]
  179. Goswami, P.; Islam, R.; Khongmalai, E.; Sarkar, B.R.; Sen, S.; Choudhury, A.; Dey, B.K. Pharmacognostical, phytochemical and anthelmintic activity of Polygonum muricatum. J. Appl. Pharm. Res. 2018, 6, 7–12. [Google Scholar] [CrossRef]
  180. Li, W.; Zhang, X.; Wu, Y.; Tian, Z. Anti-inflammatory effects and mechanism of Polygonum paleaceum Wall. extracts. Pharm. Clin. Chin. Mater. Med. 2002, 2, 18–20. [Google Scholar]
  181. Kim, S.Y.; Won, D.H.; Park, S.N. Antibacterial activity and component analysis of Persicaria perfoliata extracts. Microbiol. Biotechnol. Lett. 2010, 38, 278–282. [Google Scholar]
  182. Fu, Y.; He, X.; Li, J.; Liu, X. Chemical composition Analysis and Antibacterial effect of Polygonum perfoliatum. Prog. Vet. Med. 2008, 9, 45–49. [Google Scholar]
  183. Huang, X.; Jiang, L.; Wang, S.; Jiang, X.; Huang, D. Antibacterial activity research of medical plants of Persicaria perfoliata. J. Mod. Med. Health 2013, 29, 3041–3042. [Google Scholar]
  184. Fan, D.; Zhou, X.; Zhao, C.; Chen, H.; Zhao, Y.; Gong, X. Anti-inflammatory, antiviral and quantitative study of quercetin-3-O-β-D-glucuronide in Polygonum perfoliatum L. Fitoterapia 2011, 82, 805–810. [Google Scholar] [CrossRef] [PubMed]
  185. Tao, F.; Zhang, R.S. Research on anti-tumor effect of Polygonum perfoliatum L. in vitro and in vivo. Chin. Arch. Tradit. Chin. Med. 2013, 31, 2019–2021. [Google Scholar]
  186. Li, Q.; Fu, X.; Ge, X.; Tao, F.; Huang, P.; Ge, M.; Jin, H. Antitumor effects and related mechanisms of ethyl acetate extracts of Polygonum perfoliatum L. Front. Oncol. 2019, 9, 578. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  187. Zhang, Q.G.; Wei, F.; Liu, Q.; Chen, L.J.; Liu, Y.Y.; Luo, F.; Xiong, H.R.; Yang, Z.Q. The flavonoid from Polygonum perfoliatum L. inhibits herpes simplex virus 1 infection. Acta Virol. 2014, 58, 368–373. [Google Scholar] [CrossRef] [Green Version]
  188. Wang, Q. Preliminary Study on Anti-HBV and Hepatoprotective Activity of Polygonum perfoliatum. Ph.D. Thesis, Academy of Military Medical Sciences, Beijing, China, 2009. [Google Scholar]
  189. Xu, L.; Huang, G.; Guo, X.; Zhou, Q.; He, S. Total flavonoids, extracted from Polygonum knotweed L, exert beneficial hepatoprotection against liver injury. J. Cell. Biochem. 2019, 120, 12677–12683. [Google Scholar] [CrossRef] [PubMed]
  190. Rehman, A.; Waheed, A.; Tariq, R.; Zaman, M.; Tahir, M.J. Anti-fibrotic effects of Polygonum plebeium r. br. in CCl4-induced hepatic damage and fibrosis in rats. Biomed. Res. Ther. 2018, 5, 2223–2234. [Google Scholar] [CrossRef]
  191. Mazid, A.; Datta, B.K.; Nahar, L.; Rashid, A.; Bachar, S.C.; Bashar, S.K.; Sarker, S.D. Analgesic and diuretic properties of α-santalone from Polygonum flaccidum. Phytother. Res. 2010, 24, 1084–1087. [Google Scholar] [CrossRef] [PubMed]
  192. Lee, S.K.; Kwon, B.M.; Baek, N.I.; Kim, S.H.; Lee, J.H.; Park, H.W.; Kim, J.S.; Moon, M.K.; Kim, D.K.; Kim, D.K. Anti-proliferation effects of isorhamnetin isolated from Persicaria thunbergii on cancer cell lines. Nat. Prod. Sci. 2006, 12, 214–216. [Google Scholar]
  193. Khan, H.; Saeed, M.; Khan, M.A.; Dar, A.; Khan, I. The antinociceptive activity of Polygonatum verticillatum rhizomes in pain models. J. Ethnopharmacol. 2010, 127, 521–527. [Google Scholar] [CrossRef]
  194. Amin, M.N.; Majumder, M.S.; Moghal, M.M.R.; Banik, S.; Kar, A.; Hossain, M.M. Anthelmintic and cytotoxic activities of two medicinal plants: Polygonum viscosum and Aphanamixis polystachya growing in Bangladesh. J. Sci. Res. 2014, 6, 339–345. [Google Scholar] [CrossRef] [Green Version]
  195. Datta, B.; Datta, S.; Khan, T.; Kundu, J.; Rashid, M.; Nahar, L.; Sarker, S. Anti-cholinergic, cytotoxic and anti-HIV-1 activities of sesquiterpenes and a flavonoid glycoside from the aerial parts of Polygonum viscosum. Pharm. Biol. 2004, 42, 18–23. [Google Scholar] [CrossRef]
  196. Datta, B.K.; Datta, S.K.; Chowdhury, M.M.; Khan, T.H.; Kundu, J.K.; Rashid, M.A.; Nahar, L.; Sarker, S.D. Analgesic, antiinflammatory and CNS depressant activities of sesquiterpenes and a flavonoid glycoside from Polygonum viscosum. Pharmazie 2004, 59, 222–225. [Google Scholar] [CrossRef] [PubMed]
Table
Table 1. Origin, distribution and pharmacological uses of Persicaria and Polygonum species.
Table 1. Origin, distribution and pharmacological uses of Persicaria and Polygonum species.
SpeciesOrigin/DistributionPharmacological ActivityRef.
Persicaria genus
Persicaria acuminata (Kunth) M.GómezFrom Mexico to South AmericaAntifungal; Antinociceptive; Anti-malarial[9,25,26]
Persicaria alpina (All.) H.GrossNative to Europe and temperate AsiaAnti-inflammatory; Anti-helminthic[27]
Persicaria amphibia (L.) DelarbreNative to Europe, Asia, North America, and parts of AfricaAntifungal; Antibacterial; Anti-cancer[28,29]
Persicaria amplexicaulis (D.Don) Ronse Decr.Native to China, the Himalayas and PakistanAntioxidant; Anti-cancer; Hepatoprotective[30,31,32,33,34]
Persicaria barbata (L.) H.HaraNative to Southeast AsiaAnti-inflammatory; Antinociceptive; Anti-cancer; Diuretic; Gastroprotective[35,36,37,38]
Persicaria bistorta (L.) SampNative to Europe and Central and West AsiaAntioxidant; Anti-inflammatory; Anti-cancer; Antipyretic; Hepatoprotective; Gastroprotective[39,40,41,42,43,44,45,46,47]
Persicaria capitata (Buch.Ham. ex D.Don) H.GrossNative to China, India, Nepal, Malaysia, Thailand, Vietnam and Sri LankaAntibacterial; Anti-inflammatory[48]
Persicaria chinensis (L.) H. GrossNative to South Asian regions with sub-tropical and warm climateAntifungal; Antibacterial; Antioxidant; Anti-inflammatory; Anti-cancer; Antiviral; Anti-helminthic; Gastroprotective[49,50,51,52,53,54,55,56,57]
Persicaria decipiens (R.Br.) K.L.WilsonNative to AustraliaAnti-cancer[58,59]
Persicaria ferruginea (Wedd.) SojákNative to temperate climates of South America countriesAntifungal; Antibacterial; Antiviral; Anti-trypanocide[8,26,60,61]
Persicaria glabra (Willd.) M.GómezNative to North America and EurasiaAntibacterial; Antioxidant; Anti-inflammatory; Anti-cancer; Antiviral; Anti-malarial; Anti-leishmanial; Antipyretic; Hepatoprotective; Neuropharmacological[62,63,64,65,66,67,68,69,70]
Persicaria hydropiper (L.) DelarbeDistributed in the northern hemisphereAntifungal; Antibacterial; Antioxidant; Anti-inflammatory; Antinociceptive; Anti-cancer; Anti-trypanocide; Anti-helminthic; Anti-diabetic; Antipyretic; Neuropharmacological; Gastroprotective[71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93]
Persicaria hydropiperoides (Michx.) SmallNative to America, from Canada to Argentina and Chile (introduced in Europe)Antifungal; Antibacterial; Anti-leishmanial[19,73,94,95]
Persicaria lapathifolia (L.) DelarbreNative to Europe and Asia (introduced in America)Antifungal; Antibacterial; Antioxidant; Anti-inflammatory; Anti-cancer; Antiviral; Anti-helminthic; Anti-diabetic; Diuretic[96,97,98,99,100,101]
Persicaria limbata (Meisn.) H.HaraDistributed in the southwest of Africa, Egypt and tropical AsiaAnti-cancer[102,103]
Persicaria maculosa GrayNative to Europe and Asia (introduced in North America)Antifungal; Antibacterial; Antioxidant; Neuropharmacological[11,104,105,106,107,108,109]
Persicaria minor (Huds.) OpizNative to Europe (introduced in Australia and America)Antibacterial; Antioxidant; Anti-inflammatory; Anti-cancer; Antiviral; Hepatoprotective; Neuropharmacological; Gastroprotective[110,111,112,113,114,115,116,117,118,119,120,121,122,123,124]
Persicaria orientalis (L.) SpachNative to India (naturalized in America)Antioxidant; Anti-inflammatory; Anti-cancer; Anti-diabetic; Hepatoprotective; Neuropharmacological[125,126,127,128,129,130,131,132,133]
Persicaria pulchra (Blume) SojákDistributed in India and AfricaHepatoprotective[134,135]
Persicaria punctata (Elliott) SmallNative to America (from Canada to Argentina and Chile)Antifungal; Antibacterial; Anti-inflammatory; Antiviral[136,137,138,139,140,141]
Persicaria sagittata (L.) H.GrossDistributed in southeastern North AmericaAntioxidant[142]
Persicaria senegalensis (Meisn.) SojákDistributed in south-central AfricaAntifungal; Antibacterial; Antioxidant; Anti-cancer; Anti-diabetic[58,108,143,144]
Persicaria stagnina (Buch.Ham. ex Meisn.) QaiserDistributed in Pakistan, India, Bangladesh and MyanmarAnti-inflammatory; Anti-cancer[37,145]
Persicaria tinctoria (Aiton) H.GrossNative to Southeast AsiaAntibacterial; Antioxidant; Anti-inflammatory; Anti-cancer; Antiviral[146,147,148,149,150,151,152,153,154,155]
Persicaria vivipara (L.) Ronse Decr.Distributed in the High ArcticAnti-inflammatory[156]
Polygonum genus
Polygonum arenastrum BoreauDistributed in Europe, North Africa, Southwest Asia and North AmericaAntifungal[157]
Polygonum aviculare L.Native to Europe; It is distributed all over the worldAntifungal; Antibacterial; Antioxidant; Anti-cancer; Anti-diabetic; Neuropharmacological[158,159,160,161,162,163,164,165,166]
Polygonum bellardii All.Distributed in central-northern Europe, North Africa and Southwest AsiaAntifungal; Antibacterial; Antioxidant; Anti-inflammatory; Anti-cancer[167,168]
Polygonum cognatum Meisn.Distributed from central Asia to occidental AsiaAntifungal; Antibacterial; Antioxidant; Anti-cancer; Anti-diabetic[169,170]
Polygonum equisetiforme Sm.Distributed in southern Europe, North Africa and Southwest AsiaAntioxidant; Hepatoprotective[171,172]
Polygonum jucundum Meisn.Distributed in the Chinese provincesAnti-inflammatory[173]
Polygonum maritimum L.Native to Europe. It is distributed in North Africa, Southwest Asia and North AmericaAntifungal; Antibacterial; Antioxidant; Anti-inflammatory; Anti-diabetic; Neuropharmacological[174,175,176,177,178]
Polygonum muricatum Meisn.Distributed in India, Malaysia and NepalAnti-helminthic[179]
Polygonum paleaceum Wall.Distributed in China and IndiaAntioxidant; Anti-inflammatory[24,180]
Polygonum perfoliatum L.Native to East Asia (China, Japan, Indonesia, Malaysia, Nepal, Korea and Philippines)Antibacterial; Anti-inflammatory; Anti-cancer; Antiviral; Hepatoprotective[20,181,182,183,184,185,186,187,188,189]
Polygonum plebeium R.Br.Native to Madagascar, South Asia and New Zealand (introduced in United States and Australia)Hepatoprotective[190]
Polygonum pubescens BlumeNative to central-south AsiaAnti-inflammatory; Diuretic[191]
Polygonum thunbergii Siebold & Zucc.Native to Southeast Asia (China, India, Japan, Korea and Taiwan)Anti-cancer[192]
Polygonum verticillatum Biroli ex Colla Antinociceptive[193]
Polygonum viscosum Buch.Ham. ex D. DonNative to Nepal and widely distributed in Bangladesh, northeast India, Japan and ChinaAnti-cancer; Antiviral; Anti-helminthic; Neuropharmacological[194,195,196]
Table
Table 2. Antimicrobial activity of Persicaria and Polygonum species against human fungal and bacterial pathogens. Extracts, compounds, part of plant used, antimicrobial activity, standard drug and references are shown. Extracts: DCM (dichloromethane); EtOH (ethanol); MeOH (methanol); Chl (chloroform); Hex (hexane); EtOAc (ethyl acetate); But (butanol). Part used: L (leaves); F (flowers); R (roots); Sp (sprouts); S (seeds); St (stems); WP (whole plant); AP (aerial parts).
Table 2. Antimicrobial activity of Persicaria and Polygonum species against human fungal and bacterial pathogens. Extracts, compounds, part of plant used, antimicrobial activity, standard drug and references are shown. Extracts: DCM (dichloromethane); EtOH (ethanol); MeOH (methanol); Chl (chloroform); Hex (hexane); EtOAc (ethyl acetate); But (butanol). Part used: L (leaves); F (flowers); R (roots); Sp (sprouts); S (seeds); St (stems); WP (whole plant); AP (aerial parts).
SpeciesExtract/Isolated CompoundsPart UsePathogenGrowth Inhibition (mm or %)/MIC/IC50Standard DrugRef.
P. acuminataPolygodial (isolated from DCM extract)LCandida albicans and Cryptococcus neoformansMIC 3.9–62.5 μg/mLAmphotericin B (MIC 0.25–0.78 μg/mL)[25]
Polygodial, isopolygodial and drimenol (isolated from DCM extract)Microsporum gypseum, Trichophyton rubrum and T. mentagrophytesMIC 62.5 μg/mLAmphotericin B (MIC 0.075–0.12 μg/mL)
P. amphibiaAqueous and EtOHF, LStaphylococcus aureus11–14 mmChloramphenicol (inhibition of 27 mm)[28]
P. capitataAqueous and EtOH (tannin-enriched and flavonoid-enriched fractions)WPS. aureus, Escherichia coli, Neisseria gonorrhoeae, Klebsiella pneumoniae and Proteus mirabilisMIC 0.0022–1.37 mg/mL (Aqueous extract); 0.375–15 mg/mL (other fractions)Ciprofloxacin (MIC 0.125–0.625 μg/mL)[48]
Aqueous and EtOH (gallic acid, triterpenoid and steroid-enriched fractions)N. gonorrhoeaeMIC 0.375–4 mg/mL
P. chinensisMeOH, aqueous, Chl and petroleum ether extractLC. albicans and C. krusei7–18.67 mmFluconazole, 30µg/disc (19.67–20.33 mm)[49]
K. pneumoniae, Bacillus cereus, Streptococcus viridians, Corynebacterium diphtheriae, Enterobacter aerogenes. Pseudomonas aeruginosa and Corynebacterium diphtheriae7.33–22.33 mmAmoxicillin, 10 µg/disc (13–30.67 mm)
MeOH, aqueous, Chl and petroleum ether extractWPC. albicans, T. rubrum, Aspergillus niger, A. flavus and Cryptococcus neoformans11–21 mm (MIC 250–500 µg/mL)Amphotericin B (22–28 mm, MIC 30 µg/mL)[50]
K. pneumoniae, P. aeruginosa, Bacillus coagulans, B. subtilis, B. megaterium, B. aerogenes, Lactobacillus leichmanii and Salmonella typhi12–15 mm (MIC 250–500 µg/mL)Tetracycline (25–38 mm, MIC 15.5–31.5 µg/mL)
P. ferrugineaCardamonin (isolated from DCM extract)APEpidermophyton floccosumMIC 6.2 µg/mLAmphotericin B (MIC 0.4–0.75 µg/mL); Terbinafine (MIC 0.004–0.04 µg/mL)[8]
Crude MeOH extract, sub-extracts (n-Hex and DCM) and Pashanone isolated from DCM extractE. floccosum, M. gypseum, T. mentagrophytes and T. rubrumMIC 25–125 µg/mL
Pashanone (isolated from DCM)C. albicans, C. neoformans and Saccharomyces cerevisiaeMIC 25–50 µg/mL
P. glabraMeOH and EtOAc extractsWPB. subtilis and Proteus vulgaris4–7 mm (MIC of 0.5–1 mg/mL) [62]
2-methoxy-5-oxo-2,5-dihydrofuran-3-yl (2E)-(−)-3-phenylprop-2-enoate, 3-hydroxy-5-methoxystilbene and (-)-pinocembrin (isolated from MeOH extract)APMycobacterium tuberculosisIC50 values of 2.27, 3.33 and 1.21 μg/mL, respectively [63]
P. hydropiperConfertifolin (isolated from essential oils)LE. floccosum and Curvularia lunataMIC 7.81 μg/mLFor fungi: Ketoconazole (MIC < 12.5 μg/mL); for bacteria: Streptomycin (MIC 25 μg/mL)[71]
Enterococcus faecalisMIC 31.25 μg/mL
Drimenol (isolated from essential oils)T. mentagrophytes, T. rubrum, T. simii and A. nigerMIC < 12.5 μg/mL[72]
Chl extractRA. niger, A. flavus, A. fumigatus and T. rubrum17–20 mm
B. subtilis, B. megaterium, S. aureus, E. aerogenes, E. coli, P. aeruginosa, S. typhi and Shigella sonnei22–25 mm (MIC 16–64 µg/mL)Kanamycin, 30 µg/disc (32.7–35 mm, MIC 2–8 µg/mL)
PolygodialSpC. albicans, C. krusei, C. neoformans, S. cerevisiae, T. mentagrophytes, T. rubrum and Penicillium marneffeiMIC 0.39–6.25 µg/mLAmphotericin B (MICs 0.2–1.56 µg/mL).[73]
Crude MeOH extract and its fractions (saponins, chloroform and ethyl acetate sub-extract)WPProteus mirabilis20–30 mm (MIC 25–40.5 μg/mL)Ceftriaxone (35 mm, MIC 10 μg/mL)[74]
Acetone and EtOH extractsL, StK. pneumoniae, Haemophilus influenzae, Morganella morganii10–19 mmAmpicillin 10 µg (17–20 mm)[75]
P. hydropiperoidesPolygodial (isolated from MeOH extract)F, SpC. albicans, C. krusei, C. neoformans, C. utilis, S. cerevisiae, T. mentagrophytes, T. rubrum, P. marneffei and P. chrysogenumMIC 0.78–12.5 µg/mLAmphotericin B (MIC 0.2–1.56 µg/mL)[73]
EtOH extractLS. aureus9 mm [94]
Triterpenoids, tannins and flavonoids (isolated from MeOH extract)F, LSalmonella typhimurium16–19 mmThymol[19]
P. lapathifoliaPinostrobin chalcone and Pashanone (isolated from crude extract)STrichoderma sp., Fusarium sp., Aspergillus sp. and Penicillium sp.10–22 mmClotrimazole (15–23 mm)[96]
E. coli12–18 mmGentamycin (17–19 mm)
Flavokawin and Pashanone (isolated from crude extract)S. aureus9–13 mm
P. maculosaDCM extract and isolated compounds (polygodial, isopolygodial and pinostrobin)APM. gypseum, T. rubrum and T. mentagrophytesMIC 7.8–62.5 μg/mLKetoconazole (MIC 0.02–0.25 μg/mL) and Amphotericin (MIC 0.07–0.5 μg/mL)[11]
Polygodial (isolated from DCM extractC. albicans, C. neoformans and S. cerevisiae,MIC 15.6–500 μg/mL
PersilbenWPTrychophyton sp.MIC 125–250 mg/L [104]
MeOH extractLE. coli100%Ampicillin, 1 mg/mL[105]
S. typhi and P. aeruginosa42–49%
Quinic, gallic and chlorogenic acid and quercetin 3-O-β-d-glucopyranoside (isolated from EtOH extract)APP. aeruginosa and Salmonella entericaInhibition of biofilm formation of 50%Dimethyl sulfoxide 0.1% (DMSO)[106]
Pyocyanin production (toxin secreted by P. aeruginosa)47%
P. minorMeOH and EtOH extracts (50 and 70%)LE. coli, B. subtilis and S. aureus11.9–16.2 mm [110]
MeOH, Chl and petroleum ether extractsHelicobacter pylori12.3–15.5 mm [111]
Aqueous-EtOH (30%) and aqueous (100%) extractsE, faecalis, E. coli and S. aureus16.45–19.5 mm (concentration of 200 mg/mL)Penicillin (20.7–25.5 mm at concentration of 10 mg/mL)[112]
Hex, DCM and MeOH extractsB. cereus12.5–14.5 mm (MIC of 1.25–2.5 mg/mL)Ampicillin (17.5 mm; MIC of 0.1 mg/mL)[113]
P. punctataPolygodial (isolated from DCM extract) and DCM extractAPC. albicans, A. niger and Mucor sp. [136,137]
B. subtilis, S. aureus and Micrococcus luteus
MeOH extractE. faecalis, S. aureus, B. subtilis and Mycobacterium phlei [138]
Isotadeonal and ethyl ether extractP. aeruginosa and S. aureus75% (concentration of 100 µg/mL) [139]
P. senegalensisPyrazolines derivates of chalconesAPC. krusei, C. neoformans, S. aureus and C. glabrata,IC50 7.56–13.74 µg/mLAmphotericin B (IC50 0.37–1.38 µg/mL) and Ciprofloxacin (IC50 0.09 µg/mL)[143]
Hydroalcoholic (50%) extractLE. faecalis, B. subtilis and S. aureusMIC 1.25–5 mg/mL [144]
P. tinctoriaExtract and tryptanthrin isolated from this extractLStreptococcus mutans, S. sobrinus, Porphyromonas gingivalis, Campylobacter rectus, Prevotella intermedia and Actinobacillus actinomycetemcomitansMIC 1.74–3.48 µg/mL (for extract) and 6.25–25 ug/mL (for tryptanthrin) [146]
Kaempferol (isolated from leaves extract)S. mutans, S. sobrinus, P. gingivalis and P. intermediaMIC 25–50 µg/mL
TryptanthrinWPH. pyloriInhibited 100% colony formation (dose of 10 µg/mL)Amoxicillin, clarithromycin and omeprazole[147]
P. arenastrumMeOH extractL, StC. albicansMIC 250 μg/mLChloramphenicol (MIC 0.156–1.25 μg/mL), amphotericin B and ketoconazole (MIC 0.04–0.31 μg/mL)[157]
C. kruseiMIC 62.5–15.63 μg/mL
P. aviculareChl extractStA. niger, A. flavus and A. fumigatus14–18 mm (MIC 1–5 mg/mL)Cotrimoxazole antibiotic, 10 mg/g (18–34 mm)[158]
E. coli, P, mirabilis, P. aeruginosa, S. typhi, S. aureus and B. subtilis24–28 mm (MIC 8–15 mg/mL)
EtOH extractAPP. aeruginosa, S. aureus and Acinetobacter baumannii74–100% (at a concentration 1 mg/mL) [159]
P. bellardiiMeOH and EtOAc extracts, n-Hex, Chl and n-But fractionsAPC. albicans11–20 mm (MIC 1–25 mg/mL)Nystatin antibiotics, 25 µg/disc[167]
S. aureus, B. subtilis, E. coli and P. aeruginosa11–30 mm (MIC 1–5 mg/mL)Cefotax, 15–30 ug/disc
P. cognatumEtOH extractLC. albicansMIC 2.5 mg/mL [169]
S. aureus, P. aeruginosa and E. coliMIC 0.156–0.625 mg/mL
WPK. pneumoniae, S. aureus, E. coli, B. megatarium, C. albicans8–10 mmCeftriaxone and Nystatin 30 µg/disk (10–11 mm)[170]
P. maritimumPhenolic compounds (isolated from EtOH extract)APPenicillium sp., Aspergillus sp., Alternaria alternata and Fusarium semitectum19–34% (concentration of 1–5 mg/mL) [174]
Crude extractB. cereus, B. subtilis, S. aureus, A. baumannii, E. faecalis, P. mirabilis and Citrobacter freundiiMIC 0.12–4.02 mg/mL [175]
E. coli and P. aeruginosaMIC 16.08–64.35 mg/mL
P. perfoliatumEtOAc fractionAPS. aureus and Cutibacterium acnesMIC of 0.25%,Quercetin (MIC of 0.06–0.3%) and methyl paraben (MIC 0.13–0.25%)[181]
Water extractS. aureus, E. coli, Streptococcus sp., Salmonella sp. and Pasteurella sp.0.56–21.86 mm (MIC 0.031–0.063 mg/mL) [182]
EtOH (75%)S. aureus, B. subtilis and P. aeruginosaMIC 5–10 mg/mL [183]
Table
Table 3. Antioxidant activity of Persicaria and Polygonum species. Extracts, compounds, part of plant used, antioxidant activity and references are shown. Extracts: DCM (dichloromethane); EtOH (ethanol); MeOH (methanol); EtOAc (ethyl acetate); But (butanol). Part used: L (leaves); F (flowers); R (roots); Sp (sprouts); Sh (shoots); S (seeds); St (stems); Rh (rhizomes); WP (whole plant); AP (aerial parts). Antioxidant assays: DPPH (2,2-diphenyl-2-picryl hydroxyl); TEAC (Trolox Equivalent Antioxidant Capacity); CUPRAC (Cupric Reducing Antioxidant Capacity); ABTS ((2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)); NBT (Nitroblue tetrazolium); FRAP (Ferric Reducing Antioxidant Power); ORAC (Oxygen Radical Absorbance Capacity assay); CCA (Copper Chelating Activity).
Table 3. Antioxidant activity of Persicaria and Polygonum species. Extracts, compounds, part of plant used, antioxidant activity and references are shown. Extracts: DCM (dichloromethane); EtOH (ethanol); MeOH (methanol); EtOAc (ethyl acetate); But (butanol). Part used: L (leaves); F (flowers); R (roots); Sp (sprouts); Sh (shoots); S (seeds); St (stems); Rh (rhizomes); WP (whole plant); AP (aerial parts). Antioxidant assays: DPPH (2,2-diphenyl-2-picryl hydroxyl); TEAC (Trolox Equivalent Antioxidant Capacity); CUPRAC (Cupric Reducing Antioxidant Capacity); ABTS ((2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)); NBT (Nitroblue tetrazolium); FRAP (Ferric Reducing Antioxidant Power); ORAC (Oxygen Radical Absorbance Capacity assay); CCA (Copper Chelating Activity).
SpeciesExtract/Isolated CompoundsPart UsedSummarized BioactivityRef.
P. equisetiformeMeOH extractShDPPH scavenging activity from 12 to 51 mM TRE/g DW.
EC50 of reducing power = 68–210 μg/mL.
This capacity was attributed to different compounds such as quinic acid, gallic acid, (+ )-catechin, epicatechin, quercetin-3-O-β-d-galactoside, quercetin-3-O-α-l-rhamnoside and cirsiliol.		[171]
P. glabraFlavonoids, phenols, tannins, terpenoids and reducing sugars (isolated from MeOH extract)LDPPH free radicals with inhibitory concentration (IC50) of 79.81 μg/mL.[64]
P. lapathifoliaIsoquercitrin, hyperoside, quercitrin and taxifolin, gallic acid (isolated from MeOH extract)APAt a dose of 5 μM, compounds showed higher antioxidant activity than the standard quercetin (TEAC value of 1.16 μM for compounds and 1.1 μM for standard quercetin). Gallic acid was the most potent scavenger of hydroxyl radicals (inhibition of 70.8%) compared to the standards quercetin and Superoxide Dismutase (SOD) (inhibition of 66.2 and 77.2%, respectively).[97]
P. tinctoriaFlavonol O-glycosides with TMF as an aglyconeAP, S, SpDPPH scavenging activity from 500 µmol/g DW, (AP), 100 µmol/g DW (Sp) and 50 µmol/g DW (S).[148]
EtOAc fractionStDisplayed high antioxidant activity (IC₅₀ 7.17 µg/mL) with respect to L-ascorbic acid (IC₅₀ 5.5 µg/mL).[149]
MeOH extractL, FABTS radical scavenging of 99.12 and 96.35 M TE/g DW (L and F, respectively).
CUPRAC values of 78.37 and 86.22 M TE/g DW (L and F, respectively).		[150]
P. aviculareLyophilized EtOH extractWPDPPH and FRAP inhibition greater than 75% at a concentration of 50 µg/mL.
NBT greater than 90% at a concentration of 5 µg/mL.
Extract showed it can protect DNA in hydroxyl-radical-induced DNA strand scission assays.		[160]
P. cognatumEtOH extractLDPPH radical scavenging maximum of 18% and ABTS radical scavenging of 70%.
Positive control BHT (DPPH and ABTS scavenging of 80%).		[169]
P. maculosaEtOH extractAPSC50 (concentration that scavenges the free radicals by 50%) of 12.5 µg/mL.
FRAP value of 1.6 mmol TE/g extract.		[107]
PersilbenAPA 2.7 µM solution of persilben induced neutralization of DPPH radical by 40% (increase in content of persilben did not cause further reduction of DPPH).[104]
MeOH extractAPDPPH = 93.02% and FRAP = 7.3 mg/g.
Standard BHT = 86.5%.		[108]
P. senegalensisMeOH extractAPDPPH = 68.13% and FRAP = 6.2 mg/g.
Standard BHT = 86.5%.		[108]
Hydroalcoholic (50%) extractLIC50 value for DPPH radical scavenging activities = 6.8 μg/mL.
Positive control: L-ascorbic acid (IC50 value 1.25 μg/mL).		[144]
P. bistortaMeOH and EtOH extractsRIC50 value of 49.20 µg/mL (MeOH) and 61.14 µg/mL (EtOH).[39]
MeOH extract and zinc oxide nanoparticles (ZnO-NPs)RMeOH extract showed higher DPPH and diammonium salt radical scavenging activity. Moreover, ZnO-NPs synthesized from root can inhibit the ABTS radicals, with IC50 value of 40 µg/mL and a dose-dependent activity.[40]
P. amplexicaulisNine known compounds and a previously undetermined one (5, 6-dihydropyranobenzopyrone), amplexicine and gallic acid (isolated from EtOH extract)APIC50 values of 10.2 µmol/L (5, 6-dihydropyranobenzopyrone), 12.2 µmol/L (amplexicine) and 14.4 µmol/L (gallic acid).[30]
Crude MeOH extract and their fractions (But, EtOH, EtOAc and aqueous)Sh, L, RhAll fractions and parts of plant displayed antioxidant activity (IC50 between 1.03 and 58.2 μg/mL), but leaf crude MeOH and EtOAc fraction were the most effective for radical scavenging activity DPPH, with IC50 = 1.03 and 3.1µg/mL, respectively.[31]
P. chinensisMeOH extractWP, St, LPotent antioxidant activity respect to the standard L-ascorbic acid and Rutin:
IC50 from DPPH of 7.03–19.13 µg/mL.
IC50 from lipid peroxidation of 16.32–25.31 µg/mL.
IC50 from hydrogen peroxide method of 28.12–60.01 µg/mL.		[50]
EtOAc fractionAPORAC value of 0.965 μmol Trolox/mg.[51]
P. chinense var. chinense and P. chinense var. hispidumAqueous extract Exhibited moderate antioxidant activity, with IC50 values from 180.87 to 255.69 μg/mL (from chinense variety) and 182.96 to 250.84 μg/mL (from hispidum variety).
Gallic acid, chlorogenic acid, ellagic acid, quercitrin and brevifolin carboxylic acid isolated from these species could explain the antioxidant ability.		[52]
P. minorMeOH extractLDPPH inhibition of 80.3% and FRAP value of 377 µMol Fe (II) g−1.[110]
Aqueous and EtOH extractsLDPPH radical scavenging of 81.88 and 89.5% and FRAP value of 849.33 and 11,220 mmol/g, from aqueous and EtOH extracts, respectively.
Authors have hypothesized that high levels of phenolic compounds (TPC 55.5–207 mg/g) may be the reason for the high antioxidant activity of this species.		[114]
P. bellardiiEtOAc extract and isolated compoundsAPEtOAc extract showed at DPPH inhibition between 29.9 to 82.5%.
Gallic acid and quercetin showed a minimum inhibition of 42.0–43.1% and maximum inhibition of 97.1–100%, values closely related to the reference’s L-ascorbic acid and quercetin (45–99.6%).		[167]
P. hydropiperEtOAc fractionLStrongly inhibited free radicals with an IC50 value of 13.3 mg/mL.[76]
Flavonoids belonging to the quercetin familyLTEAC values of 3.46–6.14.[77]
Essential oilL, FSignificantly DPPH free radical scavenging, ABTS and H2O2, with IC50 values of 20, 180 and 45 μg/mL (for essential oil obtained from leaves) and 200, 60 and 50 μg/mL (for essential oil obtained from flowers), respectively.[78]
P. paleaceumCrude extract, EtOAc and But fractionsRhA good capacity on DPPH, with SC50 values of 16.72 µg/mL (crude extract), 10.64 µg/mL (EtOAc fraction) and 30.65 µg/mL (But fraction).
Gallic acid, caffeic acid derivatives and procyanidin are the main compounds that play an important role for the antioxidant activity of this plant.		[24]
P. sagittataGallic acid, methyl gallate, vanicoside A, quercetin, protocatechuic acid and vanicoside B (isolated from acetone extract)StGallic acid showed the most potent DPPH scavenging activity (IC50 8.88 µM), followed by methyl gallate, vanicoside A, quercetin, protocatechuic acid and vanicoside B, with IC50 values of 15.37, 26.82, 29.18, 32.38 and 35.06 µM, respectively.
Positive control: L-ascorbic acid (IC50 = 30.49 µM).		[142]
P. maritimumAcetone extractAPHigh O2 radical dot scavenging (RSA of O2) (IC50 = 40.4 μg/mL) and a moderate total antioxidant capacity and anti-lipid peroxidation (IC50 of 647 and 784 μg/mL).[176]
MeOH extractLIC50 from DPPH of 26 µg/mL, IC50 from FRAP of 48 µg/mL and IC50 from CCA of 770 µg/mL.
Benzoic acid, phloroglucinol, phytol and linolenic acid were identified as possible compounds responsible for these bioactivities.		[177]
Crude extractsAPGood antioxidant scavenging effects on DPPH radical (7.71 µg/mL).
Positive controls: BHA, L-ascorbic acid and quercetin (DPPH 2.59–2.61 µg/mL).		[175]
P. orientalisTaxifolinL, SInhibitory effect on DPPH radical of 100% at a concentration of 7.5 µmol/L and the IC50 value for taxifolin was 4.11 mmol/L.[125]
Table
Table 4. Analgesic an anti-inflammatory activity of Persicaria and Polygonum species. Extracts, compounds, part of plant used, anti-inflammatory and analgesic activity with their references are shown. Extracts: DCM (dichloromethane); EtOH (ethanol); MeOH (methanol); Hex (hexane); EtOAc (ethyl acetate); But (butanol). Part used: L (leaves); St (stems); Rh (rhizomes); Sta (stalks); WP (whole plant); AP (aerial parts).
Table 4. Analgesic an anti-inflammatory activity of Persicaria and Polygonum species. Extracts, compounds, part of plant used, anti-inflammatory and analgesic activity with their references are shown. Extracts: DCM (dichloromethane); EtOH (ethanol); MeOH (methanol); Hex (hexane); EtOAc (ethyl acetate); But (butanol). Part used: L (leaves); St (stems); Rh (rhizomes); Sta (stalks); WP (whole plant); AP (aerial parts).
SpeciesExtract/Isolated CompoundsPart UsedSummarized BioactivityRef.
P. chinensisMeOH extractAPAt a concentration of 300 μg/mL, extract significantly inhibited regulation of nitric oxide (NO) at 72% in RAW264.7 cells and prostaglandin (PGE2) production was strongly suppressed up to 53%.
These authors tested a murine HCl/EtOH-induced gastric ulcer model to evaluate the anti-inflammatory activity in vivo and found that the extract exhibited a significant anti-gastric activity, compared with the standard anti-ulcer ranitidine (40 mg/kg).		[53]
P. chinensis var. hispidumAqueous extractAPEllagic acid and quercitrin inhibited the development of xylene-induced ear edema, with significant inhibition at a dose of 400 mg/kg.[52]
P. alpinaMeOH extractRhHRBC (Human Red Blood Cell) membrane stabilization method and percentage of inhibition protein denaturation method were used for tested in vitro anti-inflammatory activity of MeOH and aqueous extracts which showed a good anti-inflammatory ability, with a membrane stabilizing activity of 81.29% and an inhibition of protein denaturation of 72.70%, compared to the standard Indomethacin (95.56 and 88.26%, respectively).[27]
P. hydropiperMeOH extractLExtract blocked the production of NO, PGE2 and tumour necrosis factor on RAW264.7 cells and peritoneal macrophages.[79]
Aqueous extractStaExtract attenuated the weight and length ratio of the colon, ameliorated the activity of MPO and the GSH content and regulated Cox-2, TNF-α and IL-1β levels in rats with TNBS-induced intestinal inflammation.[80]
P. pubescensα-Santalone (isolated from MeOH extract)APThe compound showed the most potent analgesic activity at a dose of 40 mg/kg b.w. (body weight), with an inhibition of acetic-acid-induced writhing response of 48.9%, compared to 62.2% for standard aminopyrine.[191]
P. lapathifolium var. lanatumHex and MeOH extractsWPAnti-inflammatory activity: extracts inhibited carrageenan induced inflammation in rat paw at 41.09% (Hex) and 30.15% (MeOH), with a dose of 300 mg/kg b.w. Standard drug: phenylbutazone (42.15% inhibition; at a dose of 100 mg/kg b.w.).
Analgesic activity: MeOH extract showed the highest inhibition of acetic acid-induced writhing reflex (62.29%; dose of 300 mg/kg b.w.), Standard drug: aminopyrine (69.94%).		[98]
P. bellardiMeOH extract, their fractions (EtOAc and But) and isolated compounds (quercetin/its derivatives and myricetin/its derivatives)APBut extract was the most inhibitor of 5-lipoxygenase (5-LOX) (IC50 14.20 mg/mL), followed by EtOAc extract, MeOH extract, myricetin and quercetin (23.16, 24, 34.25 and 43.81 mg/mL, respectively). In addition, EtOAc and But extracts, myricetin and its glycosylated derivatives showed a significant inhibition of PGE2 release (15.23–42.81%).[168]
P. orientalisMeOH extractLAt dose-dependent, extract exhibited a moderate inhibition percentage of haemolysis (50.37%). Positive control: hydrocortisone (inhibition of 86.56%).
Extract showed a good percentage of inhibition protein denaturation (79.22%). Positive control: diclofenac Na (inhibition of 86.85%).		[126]
EtOAc and ethyl ether extractsSt, LAll doses tested (3.75, 5 and 7.5 g/kg) of the two extracts showed anti-inflammatory and analgesic activity, significantly inhibiting ear edema and significantly decreasing writhing in mice.[127]
P. stagninaHex, EtOAc and MeOH extractsAPThe most potent analgesic activity was observed with the EtOAc extract (writhing inhibition of 50.3% at a dose of 400 mg/kg b.w.), while Hex extract showed the highest levels of anti-inflammatory activity (carrageenan-induced edema inhibition of 60.1% at a dose of 200 mg/kg b.w.), a much better effect than that of the conventional anti-inflammatory agent phenylbutazone (maximum 38.3% after 4 h).[145]
P. maritimumMeOH and DCM extractsLExtracts showed significant inhibition of NO production by LPS-stimulated RAW 264.7, at a concentration of 100 µg/mL.
β-sitosterol, stigmasterol, 1-octacosanol and linolenic acid were identified as the possible compounds responsible for these bioactivities.		[177]
Acetone extractAPExtract showed a potent ability to reduce NO production on LPS-stimulated RAW 264.7 macrophages (IC50 of 22.0 μg/mL). Positive control: L-NAME (IC50 of 27.6 μg/mL).[176]
P. jucundumEtOH extractAPExtract inhibited inflammatory reactions that cause instant irritation of the mouse ear, significantly inhibiting inflammatory mediators such as RAW264.7 cells (amurine macrophage cell line), production of NO, tumour necrosis factor TNF-α and IL-6 production in a dose-dependent manner.
Flavonoids and sesquiterpene lactones may be responsible for the anti-inflammatory effect.		[173]
P. minorAqueous and EtOH extractsAPAt a dose of 30 µg/mL, EtOH extract inhibited the activities of lipoxygenase and cyclooxygenase-1, while the aqueous extract completely reduced paw edema induced by λ-carrageenan at doses of 100 or 300 mg/kg b.w.[115]
P. punctataDecoction and EtOH-water extractWPExhibited anti-inflammatory activity against the carrageenan-induced pedal edema/Gastric intubation in vivo.[140]
P. tinctoriaTryptanthrin (isolated from EtOH extract)LCompound significantly inhibited the protein expression of iNOS and COX-2, suppressed the activation of p38 MAPK pathway and inhibited the TLR4 and MyD88 protein expression in LPS-stimulated BV2 microglial cells.[151]
Polyphenolic fractionLReduced NO synthesis in murine RAW264 macrophage cells stimulated with LPS, which showed a good analgesic activity.[148]
ExtractsStExhibited protective effects of DNA damage against oxidative stress and anti-inflammatory effects by its capacity for NO suppression in LPS-induced RAW264.7 cells.[149]
P. barbataPetroleum ether extractAPInhibition of 39.3% paw edema after 2 h at a dose of 400 mg/kg b.w. (inhibitory ability slightly higher than that of the conventional anti-inflammatory agent phenylbutazone, 38.3% after 4 h).[35]
P. vivipara2-propanol extract Exhibited anti-inflammatory activity against LPS-induced inflammation in RAW264.7 macrophages (IC50 = 270 µg/mL) by inhibiting NO, prostaglandin, interleukin and tumour necrosis factor (TNF)-α release at similar levels as positive control.[156]
P. bistortaBut extract Extract exhibited analgesic effect, as it could reduce the writhing times of the mice induced by acetic acid and raised the threshold of pain induced by hot and electric stimulation.[41]
P. paleaceumExtracts Extracts reduced malondialdehyde (MDA) content in inflamed paws, inhibited NO synthase and β-NAG activities and significantly reduced the content of NO, IL-1β and TNFα in exudates.[180]
P. glabraQuercetin and quercetin glycosidesLCompounds showed maximum effect at 90 min with latency time of 18.78 and 15.07 min, respectively (at doses of 200 mg/kg); the chemically induced writhing tests (for the evaluation of peripheral analgesic activity) showed maximum inhibition of writhing = 74.18% (quercetin) and 61.73% (quercetin glycosides) at a dose of 200 mg/kg in comparison with aspirin (dose of 50 mg/kg; inhibition of writhing = 78.41%).[65]
P. capitataAqueous and EtOH extractsWPSignificant inhibition of edema in animal models (76.19% and 71.13%, respectively) at a dose of 0.30 g/kg.[48]
P. perfoliatumQuercetin-3-O-β-d-glucuronide At a concentration of 8 mg/kg, compound suppressed ear edema induced by dimethyl benzene and peritoneal permeability induced by acetic acid in mice (45.96 and 40.10%, respectively), showing higher inhibition percentage respect to aspirin (24.62 and 34.38%, concentration 100 mg/kg).[184]
Table
Table 5. Anticancer and antitumoral activities of Persicaria and Polygonum species. Extracts, compounds, part of plant used, cell line and references are shown. Extracts: EtOH (ethanol); MeOH (methanol); Chl (chloroform); Hex (hexane); EtOAc (ethyl acetate); But (butanol). Part used: L (leaves); F (flowers); Fr (fruits); R (roots); Sp (sprouts); S (seeds); St (stems); Rz (rhizomes); T (tubers); B (barks); WP (whole plant); AP (aerial parts).
Table 5. Anticancer and antitumoral activities of Persicaria and Polygonum species. Extracts, compounds, part of plant used, cell line and references are shown. Extracts: EtOH (ethanol); MeOH (methanol); Chl (chloroform); Hex (hexane); EtOAc (ethyl acetate); But (butanol). Part used: L (leaves); F (flowers); Fr (fruits); R (roots); Sp (sprouts); S (seeds); St (stems); Rz (rhizomes); T (tubers); B (barks); WP (whole plant); AP (aerial parts).
SpeciesExtract/Isolated CompoundsPart UseCell LineSummarized BioactivityRef.
P. amphibiaFlavonoid glucosides: quercetin 3-O-β-d-glucopyranoside and quercetin-3-O-α-rhamnosyl-(1-2)-β-glucoside (isolated from butanoic fraction)APJurkatEC50 1.2 and 0.12 µM.[29]
HL60EC50 0.98 and 0.01 µM.
P. amplexicaulisFlavonoids (isolated from EtOH extract)RzHepG2, Huh-7, H22, SMMC-7721At a dose-time dependence: reduced cell viability, induced cell apoptosis and increased expression of SHP-1 (tyrosine phosphatase catalysing STAT3 dephosphorylation protein).[32]
Amplexicaule A (isolated from EtOH extract)MCF-7 and MDA-MB-435At a concentration of 150 mg/kg: suppressed tumour mass in 0.6–0.7 g (respect to positive control Capecitabine 10 mg/kg, 0.5–0.6 g), induced apoptosis in cancer cells, increased caspase-3, -8, -9 and PARP (enzymes and proteins that catalyse apoptosis) levels and suppressed MCL-1 and BCL-2 expression.[33]
P. barbataMethyl (2S,3S)-2-(3,4-dimethoxyphenyl)-4-((E)-3-ethoxy-3-oxoprop-1-en-1-yl)-7-methoxy-2,3 dihydrobenzo-furan-3-carboxylate (1) and (E)-3-((2S,3S)-2-(3,4-dimethoxyphenyl)-7-methoxy-3-(methoxy carbonyl)-2,3-dihydrobenzofuran-4-yl) acrylic acid (2) (isolated from EtOAc fraction)WPCAL-27 and NCI H460IC50 of 48.52 and 53.24 µM (for 1) and 86.95 and 93.34 µM (for 2). Standard drugs: 5-Fluorouracil, IC50 97.76 µM (for CAL-27) and Cisplatin, IC50 19 µM (for NCI H460).
Compound 1 induced apoptosis in CAL-27 cell line after 24 to 48 h treatment.		[36]
Petroleum ether extractAPPotato disc assayModerate activity, with inhibition of tumour growth of 57.1% at a concentration of 400 µg/disc and IC50 value of 290 µg/disc.Positive control: vincristine sulphate 3.125 µg/disc, 100% inhibition tumour).[37]
P. bistortaGallic acid, protocatechuic acid, syringic acid, catechol, syringol, 4-methyl catechol, myristic acid (isolated from MeOH-water extracts)RzHCCLM3Cell viability < 30% (at a dose of 200 µg/mL) and GI50 values between 86.5 to 126.8 µg/mL.[42]
Aqueous extractWPHep3BInhibited autophagosome and proteasome activity, resulting in restriction of cell motility and apoptosis induction in Hep3B cells.[43]
Zinc oxide nanoparticles (ZnO-NPs) (synthesized using P. bistorta extract)RMCF-7Effective dose-dependent activity, with a percentage of cells viability < 10% (at a concentration of 125 µg/mL).[40]
n-Hex and Chl fractions and its sub-fractionsRzP338, HepG2, J82, HL60, MCF7, LL2Fractions were effective against all cell lines, but showed the highest cytotoxicity against P338, HL60 and LL2 (IC50 < 10–62.4 µg/mL). Sub-fractions showed cytotoxicity against all cell lines, with IC50 values between < 10–91.2 μg/mL.[44]
P. chinensisCorilagin and ellagic acidWPSiHaEffective dose-dependent activity, with cell inhibition of 59 and 81% (at a concentration of 100 µM) and IC50 values of 21.5 and 28.7 µM, respectively.[54]
P. decipiensPhenolic acids and flavonoids (isolated from MeOH extract)L, SCaCo-2, PC3IC50 = 0.5–1.1 µg/mL.[58]
P. glabra(-)-pinocembrin (isolated from MeOH extract)APTHP-1, A549, PANC-1, HeLa, MCF7IC50 values between 1.88 to 11.00 mg/mL.[63]
P. hydropiperMeOH extract and its fractions (saponins, Chl and EtOAc)WPPotato disc anti-tumour assayAssays were performed on Agrobacterium tumefaciens containing tumour-inducing plasmid. Tumour inhibitions between 80 to 90% (at a dose of 1000 µg/mL) and IC50 values between 18.39 and 342.53 µg/mL.[83]
β-sitosterol and stigmasterol (isolated from Chl and EtOAc fractions)APNIH/3T3, HeLa, MCF-7Effective dose-dependent activity, with percentage of cytotoxicity between 67.05 and 87.5% and IC50 of 170–425 µg/mL (for β-sitosterol) and 60–170 µg/mL (for stigmasterol).[84]
MeOH extractAPEACCell growth inhibition of 84.54% (at a concentration of 50 mg/kg/day) and improved at a 68% the survival of mice.[85]
LSignificantly decreased tumour volume, packed cell volume and viable tumour cell and increased non-viable tumour cell. At a dose of 100 mg/kg, the median survival time (MST) was 37.21, respect to reference bleomycin (46.60).[86]
P. lapathifoliaPinostrobin (isolated from petroleum ether extract)APJurkat and HL60Dose-dependent effects, with a percentage of apoptotic cells > 70% (at a dose of 1 µM) and a percentage of necrotic cells > 80% (at a dose of 10 µM).[99]
Vanicoside B and lapathoside A (extracted with MeOH)EBV-EACarcinogenesis was induced by 7,12-dimethylbenz[a]anthracene (DMBA, as initiator), (E)-methyl-2-[(E)-hydroxyamino]-5-nitro-6-methoxy-3-hexenamide (NOR-1) and 12-O-tetradecanoylphorbol-13-acetate (TPA) as a promoter.
The number of papillomas per mouse were reduced at 3.4 and 2.6 after 15 weeks compared to the control (DMBA + TPA, 9.1 papillomas per mouse). In the NOR-1 + TPA treatment, vanicoside B reduced the number of papillomas from 7.2 (control) to 3.		[100]
P. limbataCardamomin and 2′,4′-dihydroxy-3′,6′-dimethoxychalcone (isolated from MeOH extract)APMCF-7, THP-1, PC-3, HeLaProliferation inhibition > 50%. The best activity was observed against THP-1 cell line, with IC50 < 4 µg/mL.[102]
FlavonoidsLCCRF-CEM, MDA-MB-231-pcDNA3, HCT116, U87MG, HepG2The flavonoid 4-hydroxy-2,6-dimethoxychalcone, showed the best activity against all cell lines, with IC50 values of 9.37, 19.58, 6.8, 35.25 and 58.63 µM.
The flavonoids cardamomin and 2,4-dihydroxy-3,6-dimethoxychalcone were effective against CCRF-CEM cell line (IC50 of 8.59 and 10.67 µM, respectively).		[103]
P. minorEtOAc (100%), aqueous-EtOH (50%), MeOH (100%), EtOH (70%) extracts and aqueous solution (100%)LHT-29, HCT-116, CT-26EtOAc extract (100%) showed the highest cytotoxic effect against HCT-116 and CT-26 and Aq-EtOH extract (50%) was the most effective against HT-29 cell line (IC50 of 7.0 and 24.0 µg/mL, respectively).
Aq solution (100%), MeOH (100%) and EtOH (70%) extracts showed moderate activity, with IC50 of 34.0–78.0 µg/mL (HT-29), 13.0–33.0 µg/mL (HCT-116) and 20.0–29.0 µg/mL (CT-25), respectively.
IC50 values for standard agent Doxorubicin: 0.63 (HT-29), 0.46 (HCT-116) and 0.14 µg/mL (CT-26).		[116]
Polygonumins A (extracted with MeOH)StK562, MCF7, HCT116Good activity compared to the positive control Doxorubicine (IC50 = 2.25–3.24 and 0.52–2.97 µg/mL, respectively).[117]
P. orientalisEtOAc and n-But extractsFHeLa, SMMC-7721Proliferation inhibition about 40–60% at doses between 50 to 450 µg/mL and after 48 h.[128]
EtOAc and Acetone extractsFr95DIC50 values = 199.1 mg/L (for EtOAc extract) and 261.2 mg/L (for acetone extract).[129]
P. senegalensisPhenolic acids and flavonoids (isolated from MeOH)L, SCaCo-2, PC3IC50 1.5–3.5 µg/mL.[58]
P. stagninaEtOAc and n-Hex extractsAPPotato assay discModerate activity, with inhibition of tumour growth between 50 to 78.6% at a concentration of 200–400 µg/disc and IC50 values = 180 and 200 µg/disc (for EtOAc and n-Hex extracts, respectively).
Positive control: vincristine sulphate 3.125 µg/disc, 100% inhibition tumour).		[37]
P. tinctoriaMeOH and EtOH extractsF, L, St, SHEK 293, HCT-116, HeLa, Hep3B, MCF-7, SNU-1066, SNU-601EtOH extract from flowers was the most effective against all cell lines, except for MCF-7 and SNU-601, with survival rate of cancer cells = 5.10–25.27%.
Leaves’ MeOH extract showed a good activity against HCT-116, HeLa, Hep3B and SNU-1066 (survival cancer cells = 6.89–26.47%); stems’ MeOH extract was effective against Hep3B and SNU-1066 (survival cancer cells = 26.94–29.28%); and seeds’ MeOH extract showed a good activity against HEK 293, HeLa, Hep3B and SNU-601 (survival cancer cells = 22.89–29.85%).		[150]
Tryptanthrin (isolated from EtOAc extract)LU-937, HL-60Compound showed 100% of cytocidal effects on both cell lines (at a concentration of 6.3 mg/mL) and inhibited DNA synthesis at dose-dependency.[152]
P. aviculareMeOH extractAPMCF-7The extract induced cytotoxicity in MCF-7 cell line, with a 99% of cell death at the concentration of 400 ng/µl after 24 hrs.[161]
Hela-SShowed cytotoxic effect at IC50 values between 0.27 and 0.41 mg/mL and caused complete apoptosis at 24 h of treatment.[162]
P. bellardiiMeOH, EtOAc and n-But extracts and isolated compounds (gallic acid, quercetin/its derivatives and myricetin/its derivatives)APHeLa, MCF-7, HepG-2At a concentration between 130 and 170 µg/mL, all extracts and fractions inhibited cell viability at 20% of all cell lines tested.
n-But extract was the most potent against three cell lines (IC50 = 15.26, 50.66 and 30.09 µg/mL, respectively); MeOH and EtOAc extracts showed a good activity against HeLa cells (IC50 = 48.6 and 44.14 µg/mL, respectively); and quercetin derivatives and myricetin and its derivatives were effective against HepG-2 (IC50 between 41.03 to 70.77 µg/mL).		[168]
P. cognatumEtOH extractLMDA-MB-231MDA-MB-231 cell viability < 50% and IC50 = 0.053 mg/mL.[169]
P. perfoliatum8-oxo-pinoresinol (isolated from MeOH extract)TBcap-37, SMMC-7721, K562, RKO, PC3IC50 values from 8.32 to 30.1 µg/mL (positive control Mitomycin, IC50 values from 1.75 to 6.24 µg/mL).[20]
EtOAc extractAPSmur180, SGC-7901, Colo320, PC-3, HL60Smur180 inhibition cells = 58.46% (at a dose of 200 mg/kg) and inhibited the growth and proliferation of other cell lines, with IC50 < 50 µg/mL.[185]
APPANC-1, PC-3, SGC-7901, BT-325, HepG2, A549, HelaInhibition cell lines = 70.1–90% and IC50 values between 20.6 to 40.7 µg/mL. Furthermore, the extract arrested cells at G2 phase, increased the proliferation of T and B lymphocytes, promoted the activities of NK and cytotoxic T lymphocytes (CTLs) and induced cell apoptosis.[186]
P. thunbergiiIsorhamnetinAPNIH3T3, SW620The compound decreased the percentage of cell proliferation with IC50 values of 4.1 µg/mL (for NIH3T3) and 22.4 µg/mL (for SW620).[192]
P. viscosumMeOH crude extractBBrine shrimp lethality testThe extract showed a good cytotoxic ability respect to the standard Vincristine sulphate (IC50 = 6.34 and 0.825 µg/mL, respectively).[194]
Quercetin 3-O-(6-feruloyl)-β-d-galactopyranosideWPOVCAR-3IC50 = 13.33 µg/mL. Authors considered that this effect could be attributed to the presence of moieties such as quercetin, galactosyl and principally feruloyl in this compound.[195]
Table
Table 6. Antiviral activities of Persicaria and Polygonum species. Extracts, compounds, part of the plant used, target virus and references are shown. Extracts: EtOH (ethanol); MeOH (methanol); Hex (hexane); EtOAc (ethyl acetate); But (butanol). Part used: L (leaves); F (flowers); Fr (fruits); R (roots); Sp (sprouts); S (seeds); St (stems); Rz (rhizomes); T (tubers); B (barks); WP (whole plant); AP (aerial parts).
Table 6. Antiviral activities of Persicaria and Polygonum species. Extracts, compounds, part of the plant used, target virus and references are shown. Extracts: EtOH (ethanol); MeOH (methanol); Hex (hexane); EtOAc (ethyl acetate); But (butanol). Part used: L (leaves); F (flowers); Fr (fruits); R (roots); Sp (sprouts); S (seeds); St (stems); Rz (rhizomes); T (tubers); B (barks); WP (whole plant); AP (aerial parts).
SpeciesExtract/Isolated CompoundsPart UsePathogenSummarized BioactivityRef.
P. chinensisMeOH, But and EtOAc extracts.WPH3N2-HK, H1N1-PR8, LeeEC50 = 18.3–38.4 µg/mL (for H3N2) and 45.9–70.1 µg/mL (for H1N1and Lee).[55]
Ellagic acid, methyl gallate and caffeic acid (isolated from EtOAc extract)Significantly inhibited viral replication (EC50 = 14.7–81.1 µg/mL) by suppressing virus replication in cells.
P. ferrugineaEtOH extractAPHHV-1, DEN-2, VACV-WREC50 values = 21.1, 24.6 and 34.2 µg/mL, respectively.[60]
P. glabra2-methoxy-5-oxo-2,5-dihydrofuran-3-yl (2E)-(−)-3-phenylprop-2-enoate (isolated from MeOH extract)APHIV-1VB59, HIV-1UG070IC50 values = 15.68–22.43 mg/mL.[63]
P. lapathifoliaLapathoside A and D, vanicoside B and hydropiperoside (isolated from MeOH extract)APEBV-EAInhibition of activation on EBV-EA higher than 85, 60 and 30%.[100]
P. minorPolygonumins AStHIV-1Inhibition of HIV-1 protease = 56.51% (positive control Pepstatin A, inhibition = 81.48%). The authors considered that the phenyl propanoid glycoside moiety present in Polygonumins A, may be the responsible for the anti-HIV protease activity.[117]
EtOH extractLHSV-1, VSVMIC values = 0.01 and 0.02 mg/mL (for HSV-1 and VSV, respectively).[118]
P. punctataAqueous extractAPHSV-1, RSVED50 values = 169.7 and 120 µg/mL (for HSV-1 and RSV, respectively)[141]
MeOHWPHSV-1At a MIC of 20 µg/mL, the extract caused the complete virus inactivation.[138]
P. tinctoriaMeOH and EtOAc extractsWPH1N1-PR8, HSV-1, VV, MCMV, VSVIC50 values between 1.25 and 16.6 µg/mL (for MeOH extract) and 0.63 to 50 µg/mL (for EtOAc extract).[153]
Aqueous extractLHIV-1Inhibition of HIV-1 (IIIB) infection at EC50 value of 0.5 µg/mL.[154]
P. perfoliatumQuercetin-3-O-β-d-glucuronideWPinfluenza A virusInhibition of 27.94%, at a concentration of 6 mg/kg (reference drug Ribavirin, inhibition of 23.97%).[184]
Flavonoids (extracted with MeOH and n-Hex)LHSV-1At a concentration of 62.5 µg/mL, flavonoids reduced more than 80% the number of plaques in infected cultures, in the same way as the control ACV. At a dose of 30 mg/kg/day, the survival and mean survival time (MST) of mice induced with encephalitis HSV-1 were 80% and 19.0 days, respectively, higher values compared with the control ACV (survival of 70% and MST = 18.5 days).[187]
Gallic acyl groups (isolated from n-But and water extracts)WPHBVInhibition up to 74% secretion of antigen (HBeAg).[188]
P. viscosumQuercetin 3-O-(6-feruloyl)-β-d-galactopyranoside and viscoazuloneWPHIV-1Reverse transcriptase inhibitory activity with IC50 values of 33.13 and 25.61 mg/mL (for quercetin and viscoazulone, respectively).[195]
Table
Table 7. Antiparasitic activities of Persicaria and Polygonum species. Extracts, compounds, part of the plant used, antiparasitic activity and references are shown. Extracts: EtOH (ethanol); MeOH (methanol); Hex (hexane); EtOAc (ethyl acetate). Part used: L (leaves); F (flowers); Fr (fruits); R (roots); Sp (sprouts); S (seeds); St (stems); Rz (rhizomes); T (tubers); B (barks); WP (whole plant); AP (aerial parts).
Table 7. Antiparasitic activities of Persicaria and Polygonum species. Extracts, compounds, part of the plant used, antiparasitic activity and references are shown. Extracts: EtOH (ethanol); MeOH (methanol); Hex (hexane); EtOAc (ethyl acetate). Part used: L (leaves); F (flowers); Fr (fruits); R (roots); Sp (sprouts); S (seeds); St (stems); Rz (rhizomes); T (tubers); B (barks); WP (whole plant); AP (aerial parts).
SpeciesExtract/Isolated CompoundsPart UsePathogenSummarized BioactivityRef.
Anti-malarial
P. acuminataMeOH extractLP. falciparumIC50 = 8 µg/mL[26]
P. glabraEtOH extractLPlasmodium sp.IC50 = 6.6 µg/mL[66]
Anti-trypanocide
P. decipiens2,4-dimethoxy-6-hydroxychalcone (chalcone 1) and 2,5-dimethoxy-4,6-dihydroxychalcone (chalcone 2)APT. brucei
T. congolense		EC50 = 1.8–8.8 µM (for chalcone 1) and 13.9–34 µM (for chalcone 2).
Positive controls: Diminazene (EC50 = 0.15–1.43 µM) and Pentamidine (EC50 = 0.0034–0.72 µM).		[59]
P. ferruginean-Hex, DCM and EtOAc extractsAPT. cruzi
T. brucei		IC50 values = 8.6–10.5 µg/mL (for Hex and dichloromethane extracts) and 50–90 µg/mL (for EtOAc extract).
Positive controls: Pentamidine (IC50 = 6.4 and 2.2 µg/mL) and Benznidazole (IC50 = 34.7 and 54.1 µg/mL).		[61]
2′-hydroxy-4′,6′-dimethoxychalcone, flavokawin B (1), 2′,6′-dihydroxy-3′,4′-dimethoxychalcone, pashanone (2) and (2′,4′- dihydroxy-6′-methoxychalcone, cardamonin or alpinetin chalcone (3) (isolated from Hex extract)Compounds 1, 2 and 3 were effective against T. cruzi (IC50 between 9.5 and 32.3 µM). Against T. brucei, only compound 1 was active, with IC50 = 6.2 (for strain 427) and 4.8 µM (for strain 29–13).
MeOH extractT. cruziIC50 = 37 µg/mL.[26]
P. hydropiperCardamomin, vanicoside F, ketopinoresinol, isorhamnetin and pinosylvin (isolated from DCM soluble portion)WPT. bruceiIC50 = 0.49–0.8 µg/mL (for cardamomin) and 0.49–7.77 µg/mL (for other compounds).
Positive control: α-difluoromethylornithine (DFMO), IC50 = 3.02 µg/mL.		[87]
Anti-leishmanial
P. glabraAqueous extractWPLeishmania tropicaAt a minimal concentration tested (0.05 µg/mL), extract showed a 4.23% parasite mortality, while using a concentration of 50 µg/mL, the mortality raised up to 68.1%.[67]
P. hydropiperoidesMeOH extractFLeishmania amazonensisIC50 = 73 µg/mL.[95]
Anthelmintic
P. alpinaMeOH extractRzEarthwormsEarthworms’ death times = 71.4 min at a concentration of 100 mg/mL (standard Albendazole, death time = 56.6 min).[27]
P. chinensisAqueous and MeOH extractsLPheretima posthumaInhibition and death at 5.83 and 16.5 min (for Aqueous extract), respectively, and at 9.25 and 19.67 min (for MeOH extract), respectively, at a dose = 100 mg/mL.
Standard drug: Albendazole (inhibition and death at 5.33 and 6.92 min).		[56]
P. hydropiperMeOH extractAPP. posthumaAt the extract concentration of 50 mg/mL, the time of paralysis and death of earthworms were 12.44 and 18.19 min.
Positive control: Piperazine citrate, 10 mg/mL (time of paralysis and death = 24 and 38 min, respectively).		[85]
Saponins, Chl and n-But (fractionated from MeOH extract)WPP. posthumaParalysis time between 8 and 11 min and death time between 50 and 66.33 min at a concentration of 10 mg/mL.[88]
P. lapathifoliaMeOH extractStP. posthumaAt a concentration of 60 mg/mL, the times taken for paralysis and death were 9 and 23.66 min, respectively.
Standard drug: Piperazine citrate, 10 mg/mL (time taken for paralysis and death = 9.33 and 36 min, respectively).		[101]
P. muricatumEtOH extractLEarthwormsAt a concentration of 100 mg/mL, the paralysis and death times were 35 and 43 min, respectively. Standard drug: Albendazole (paralysis and death time = 20 and 30 min, respectively).
Phytochemical analysis identified various constituents such as alkaloids, carbohydrates, glycosides, phytosterols, phenolic compounds, tannins, saponins, proteins and amino acids.		[179]
P. viscosumMeOH extract [194]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Seimandi, G.; Álvarez, N.; Stegmayer, M.I.; Fernández, L.; Ruiz, V.; Favaro, M.A.; Derita, M. An Update on Phytochemicals and Pharmacological Activities of the Genus Persicaria and Polygonum. Molecules 2021, 26, 5956. https://doi.org/10.3390/molecules26195956

AMA Style

Seimandi G, Álvarez N, Stegmayer MI, Fernández L, Ruiz V, Favaro MA, Derita M. An Update on Phytochemicals and Pharmacological Activities of the Genus Persicaria and Polygonum. Molecules. 2021; 26(19):5956. https://doi.org/10.3390/molecules26195956

Chicago/Turabian Style

Seimandi, Gisela, Norma Álvarez, María Inés Stegmayer, Laura Fernández, Verónica Ruiz, María Alejandra Favaro, and Marcos Derita. 2021. "An Update on Phytochemicals and Pharmacological Activities of the Genus Persicaria and Polygonum" Molecules 26, no. 19: 5956. https://doi.org/10.3390/molecules26195956

APA Style

Seimandi, G., Álvarez, N., Stegmayer, M. I., Fernández, L., Ruiz, V., Favaro, M. A., & Derita, M. (2021). An Update on Phytochemicals and Pharmacological Activities of the Genus Persicaria and Polygonum. Molecules, 26(19), 5956. https://doi.org/10.3390/molecules26195956

Article Metrics

Back to TopTop